{"content":"<li class=\"n-box-item date-title\" data-end=\"1527739199\" data-start=\"1527652800\" data-txt=\"Monday, December 23, 2019\">Wednesday, May 30, 2018</li><li class=\"n-box-item sa-box-item\" data-id=\"3360534\" data-ts=\"1527720109\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/P\" target=\"_blank\">P</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360534-pandora-matches-rivals-family-subscription\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pandora matches rivals with family subscription</a></h4><ul>   <li>Pandora's (NYSE:<a href='https://seekingalpha.com/symbol/P' title='Pandora Media'>P</a>) latest subscription service is set to help it compete against tough rivals in Apple (NASDAQ:<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a>) and Spotify (NYSE:<a href='https://seekingalpha.com/symbol/SPOT' title='Spotify'>SPOT</a>), its CEO says.</li>    <li>Subscriptions are \"the fastest growing part of our business,\" Roger Lynch tells CNBC in discussing the rollout of the <a href=\"https://www.cnbc.com/2018/05/30/ceo-roger-lynch-new-family-plan-allows-pandora-to-compete-with-apple-music-spotify.html?__source=twitter|main\" target=\"_blank\">Pandora Premium Family plan</a>.</li>    <li>That move catches the company up somewhat to existing family sub offerings from competitors, after losing a number of users to Apple and Spotify.</li>    <li>The new plan lets up to six family members share music for $14.99/month, and Lynch says it has a \"twist\" in a feature called \"Our Soundtrack.\"</li>    <li>Pandora shares <font color='green'>gained 3%</font> during the market session; they're <font color='red'>down 2.8%</font> after hours.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3360534\" data-linked=\"Pandora matches rivals with family subscription\" data-tweet=\"$P $P $AAPL - Pandora matches rivals with family subscription https://seekingalpha.com/news/3360534-pandora-matches-rivals-family-subscription?source=tweet\" data-url=\"https://seekingalpha.com/news/3360534-pandora-matches-rivals-family-subscription\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360524\" data-ts=\"1527716110\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NGL\" target=\"_blank\">NGL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360524-after-hours-gainers-losers-05-30-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers (05/30/2018)</a></h4><ul>     <li><b>Top gainers:</b>&nbsp;<a href='https://seekingalpha.com/symbol/NGL' title='NGL Energy Partners LP'>NGL</a>&nbsp;<font color='green'>+13.6%</font>. <a href='https://seekingalpha.com/symbol/TLYS' title='Tilly&#39;s, Inc.'>TLYS</a>&nbsp;<font color='green'>+13.0%</font>. <a href='https://seekingalpha.com/symbol/KEYS' title='Keysight Technologies Inc.'>KEYS</a> <font color='green'>+4.7%</font>. <a href='https://seekingalpha.com/symbol/WPG' title='Washington Prime Group, Inc.'>WPG</a>&nbsp;<font color='green'>+2.6%</font>. <a href='https://seekingalpha.com/symbol/AGLE' title='Aeglea BioTherapeutics'>AGLE</a> <font color='green'>+1.8%</font>.</li>     <li><strong>Top Losers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/CRSP' title='CRISPR Therapeutics'>CRSP</a> <font color='red'>-19.0%</font>. <a href='https://seekingalpha.com/symbol/EDIT' title='Editas Medicine'>EDIT</a>&nbsp;<font color='red'>-5.5%</font>.&nbsp;&nbsp;<a href='https://seekingalpha.com/symbol/CHMI' title='Cherry Hill Mortgage Investment'>CHMI</a>&nbsp;<font color='red'>-5.1%.&nbsp;</font><a href='https://seekingalpha.com/symbol/BOX' title='Box'>BOX</a>&nbsp;<font color='red'>-3.9%</font>. <a href='https://seekingalpha.com/symbol/RGNX' title='REGENXBIO'>RGNX</a>&nbsp;<font color='red'>-2.9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3360524\" data-linked=\"After Hours Gainers / Losers (05/30/2018)\" data-tweet=\"$NGL $NGL $TLYS - After Hours Gainers / Losers (05/30/2018) https://seekingalpha.com/news/3360524-after-hours-gainers-losers-05-30-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3360524-after-hours-gainers-losers-05-30-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360522\" data-ts=\"1527715850\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WIN\" target=\"_blank\">WIN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360522-windstream-launches-consent-solicitation-on-senior-secured-credit\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Windstream launches consent solicitation on senior secured credit</a></h4><ul>   <li>Windstream Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/WIN' title='Windstream Holdings, Inc.'>WIN</a>) has confirmed that subsidiaries Windstream Services and Windstream Finance Corp. are <a href=\"https://seekingalpha.com/pr/17178063-windstream-commences-consent-solicitation-amend-8_625-percent-senior-first-lien-notes-due\" target=\"_blank\">starting a consent solicitation</a> to amend the company's 8.625% senior first-lien notes due 2025, with an eye toward amending its senior secured credit facility.</li>    <li>As of today, the outstanding principal on those notes was about $600M.</li>    <li>The purpose is to allow for indebtedness on a junior lien basis and for corresponding junior lien intercreditor agreements.</li>    <li>Shares closed <font color='red'>down 10.2%</font> today after <a href=\"https://seekingalpha.com/news/3360404-windstream-reportedly-seeking-credit-amendment-shares-minus-13_3-percent\" target=\"_blank\">earlier reports</a> that it would be seeking a credit amendment. They're flat on heavy after-hours volume.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3360522\" data-linked=\"Windstream launches consent solicitation on senior secured credit\" data-tweet=\"$WIN $WINMQ - Windstream launches consent solicitation on senior secured credit https://seekingalpha.com/news/3360522-windstream-launches-consent-solicitation-on-senior-secured-credit?source=tweet\" data-url=\"https://seekingalpha.com/news/3360522-windstream-launches-consent-solicitation-on-senior-secured-credit\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360517\" data-ts=\"1527714985\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRSP\" target=\"_blank\">CRSP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360517-crispr-therapeutics-down-20-after-hours-on-ind-hold-for-sickle-cell-candidate-ctx001\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CRISPR Therapeutics down 20% after hours on IND hold for sickle cell candidate CTX001</a></h4><ul><li>CRISPR Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/CRSP' title='CRISPR Therapeutics'>CRSP</a>) slumps&nbsp;<font color='red'>20%</font>&nbsp;after hours on robust volume in response to its <a href=\"https://www.sec.gov/Archives/edgar/data/1674416/000119312518178592/d596458dex991.htm\" target=\"_blank\">disclosure </a>that the FDA has placed a clinical hold on its IND for sickle cell disease &#40;SCD&#41; gene therapy candidate CTX001. The suspension will be in effect pending the resolution of certain questions related to the application.</li><li>Once approved, a U.S.-based Phase 1/2 study in adult SCD patients will commence. A Phase 1/2 study in adults with transfusion-dependent beta-thalassemia should start in H2 in Europe.</li><li>The company is co-developing the therapy with collaboration partner Vertex Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/VRTX' title='Vertex Pharmaceuticals Incorporated'>VRTX</a>).</li><li>SCD-related tickers: (NASDAQ:<a href='https://seekingalpha.com/symbol/GBT' title='Global Blood Therapeutics'>GBT</a>)(NASDAQ:<a href='https://seekingalpha.com/symbol/BLUE' title='bluebird bio, Inc.'>BLUE</a>)(NASDAQ:<a href='https://seekingalpha.com/symbol/SNY' title='Sanofi'>SNY</a>)(NASDAQ:<a href='https://seekingalpha.com/symbol/SGMO' title='Sangamo Therapeutics, Inc.'>SGMO</a>)(NASDAQ:<a href='https://seekingalpha.com/symbol/IRWD' title='Ironwood Pharmaceuticals, Inc.'>IRWD</a>)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3317826-crispr-therapeutics-vertex-team-advance-commercialize-lead-gene-editing-candidate-blood\" target=\"_blank\">CRISPR Therapeutics and Vertex team up to advance and commercialize lead gene editing candidate for blood disorders</a> (Dec. 12, 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3360517\" data-linked=\"CRISPR Therapeutics down 20% after hours on IND hold for sickle cell candidate CTX001\" data-tweet=\"$CRSP $CRSP $VRTX - CRISPR Therapeutics down 20% after hours on IND hold for sickle cell candidate CTX001 https://seekingalpha.com/news/3360517-crispr-therapeutics-down-20-after-hours-on-ind-hold-for-sickle-cell-candidate-ctx001?source=tweet\" data-url=\"https://seekingalpha.com/news/3360517-crispr-therapeutics-down-20-after-hours-on-ind-hold-for-sickle-cell-candidate-ctx001\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>68&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360499\" data-ts=\"1527712634\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SMTC\" target=\"_blank\">SMTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360499-semtechminus-0_9-on-q1-beats-in-line-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Semtech -0.9% on Q1 beats, in-line guidance</a></h4><ul><li>        Semtech (NASDAQ:<a href='https://seekingalpha.com/symbol/SMTC' title='Semtech Corporation'>SMTC</a>)&nbsp;<font color='red'>drops 0.9%</font>&nbsp;aftermarket on Q1 results that beat EPS and revenue estimates with a 2% Y/Y revenue growth. In-line Q2 guidance has revenue of $155M to $167M (consensus: $160.32M) and EPS from $0.50 to $0.58 (consensus: $0.53).</li><li>               Capital allocation: Board approves an additional $250M share repurchase under the existing program, bringing the total to $272M.&nbsp;</li><li>                  Earnings call is scheduled for 5 PM Eastern with a webcast available <a href=\"https://www.semtech.com/\" target=\"_blank\">here</a>.    </li><li>               <a href=\"https://seekingalpha.com/pr/17177971-semtech-announces-first-quarter-fiscal-year-2019-results\" target=\"_blank\">Press release</a>. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3360481-semtech-beats-0_01-beats-revenue\" target=\"_blank\">Semtech beats by $0.01, beats on revenue</a> (May 30)</li></ul><div class=\"tiny-share-widget\" data-id=\"3360499\" data-linked=\"Semtech -0.9% on Q1 beats, in-line guidance\" data-tweet=\"$SMTC - Semtech -0.9% on Q1 beats, in-line guidance https://seekingalpha.com/news/3360499-semtechminus-0_9-on-q1-beats-in-line-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3360499-semtechminus-0_9-on-q1-beats-in-line-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:37 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360494\" data-ts=\"1527712384\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TLYS\" target=\"_blank\">TLYS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360494-tillys-beats-0_03-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tilly&#39;s beats by $0.03, beats on revenue</a></h4><ul><li>Tilly's (NYSE:<a href='https://seekingalpha.com/symbol/TLYS' title='Tilly&#39;s, Inc.'>TLYS</a>): Q1 EPS of $0.04 <font color='green'>beats by $0.03</font>.</li><li>Revenue of $123.63M (+2.2% Y/Y) <font color='green'>beats by $1.77M</font>.</li><li>Shares <font color='green'>+9.5%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17177930-tilly-s-inc-announces-fiscal-2018-first-quarter-results\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3360494\" data-linked=\"Tilly&#39;s beats by $0.03, beats on revenue\" data-tweet=\"$TLYS - Tilly&#39;s beats by $0.03, beats on revenue https://seekingalpha.com/news/3360494-tillys-beats-0_03-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3360494-tillys-beats-0_03-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:33 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360491\" data-ts=\"1527712215\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KEYS\" target=\"_blank\">KEYS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360491-keysight-technologiesplus-1_8-on-q2-revenue-beat-upside-rev-guide\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Keysight Technologies +1.8% on Q2 revenue beat, upside rev. guide</a></h4><ul><li>        Keysight Technologies (NYSE:<a href='https://seekingalpha.com/symbol/KEYS' title='Keysight Technologies Inc.'>KEYS</a>)&nbsp;<font color='green'>gains 1.8%&nbsp;</font>aftermarket on Q2 results that met EPS estimates but beat on revenue with a 32% Y/Y revenue growth. Q3 guidance has upside revenue from $942M to $972M (consensus: $916.44M) and in-line EPS from $0.72 to $0.82 (consensus: $0.74). &nbsp;</li><li>           Earnings call is scheduled for 4:30 PM Eastern with a webcast available <a href=\"https://investor.keysight.com/investors-relations/investor-news-and-events/upcoming-events/default.aspx\" target=\"_blank\">here</a>. </li><li> <a href=\"https://seekingalpha.com/pr/17177940-keysight-technologies-reports-second-quarter-2018-results\" target=\"_blank\">Press release</a>.&nbsp; </li><li>Previously: <a href=\"https://seekingalpha.com/news/3360466-keysight-eps-line-beats-revenue\" target=\"_blank\">Keysight EPS in-line, beats on revenue</a> (May 30)</li></ul><div class=\"tiny-share-widget\" data-id=\"3360491\" data-linked=\"Keysight Technologies +1.8% on Q2 revenue beat, upside rev. guide\" data-tweet=\"$KEYS - Keysight Technologies +1.8% on Q2 revenue beat, upside rev. guide https://seekingalpha.com/news/3360491-keysight-technologiesplus-1_8-on-q2-revenue-beat-upside-rev-guide?source=tweet\" data-url=\"https://seekingalpha.com/news/3360491-keysight-technologiesplus-1_8-on-q2-revenue-beat-upside-rev-guide\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360490\" data-ts=\"1527712194\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PVH\" target=\"_blank\">PVH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360490-pvh-lifts-full-year-profit-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PVH lifts full-year profit guidance</a></h4><ul> <li>PVH (NYSE:<a href='https://seekingalpha.com/symbol/PVH' title='PVH Corp.'>PVH</a>) reports sales rose 10% in <a href=\"https://seekingalpha.com/pr/17177981-pvh-corp-reports-2018-first-quarter-revenue-eps-guidance-raises-full-year-eps-outlook\" target=\"_blank\">FQ1</a> on a constant currency basis as both the Calvin Klein and Tommy Hilfiger brands saw momentum.</li> <li>Revenue was up 12% for the CK business on a constant currency basis and 11% for the Tommy Hilfiger brand.</li> <li>The company lifts guidance after knocking out the solid quarter, now seeing full-year revenue growth of 6% and full-year EPS of $9.05 to $9.15 vs. $9.00 to $9.10 prior and $9.12 consensus.</li> <li>PVH <font color='green'>+0.32%</font> AH to $156.00.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3360490\" data-linked=\"PVH lifts full-year profit guidance\" data-tweet=\"$PVH - PVH lifts full-year profit guidance https://seekingalpha.com/news/3360490-pvh-lifts-full-year-profit-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3360490-pvh-lifts-full-year-profit-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360489\" data-ts=\"1527712157\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/T\" target=\"_blank\">T</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360489-ts-stephenson-sprint-t-mobile-might-succeed-despite-uphill-battle\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AT&amp;T&#39;s Stephenson: Sprint/T-Mobile might succeed despite &#39;uphill battle&#39;</a></h4><ul>   <li>AT&amp;T (NYSE:<a href='https://seekingalpha.com/symbol/T' title='AT&T Inc.'>T</a>) chief Randall Stephenson says a proposed combination of Sprint (NYSE:<a href='https://seekingalpha.com/symbol/S' title='Sprint Corporation'>S</a>) with T-Mobile (NASDAQ:<a href='https://seekingalpha.com/symbol/TMUS' title='T-Mobile US, Inc.'>TMUS</a>) might <a href=\"https://www.axios.com/att-ceo-stephenson-on-tmobile-sprint-fb0df646-dac7-478e-bd75-67b1883722a0.html\" target=\"_blank\">succeed where he failed</a> -- in his own bid to acquire T-Mobile.</li>    <li>That doesn't mean the wireless merger is anything close to an assured deal, he said at Code Conference, noting things have changed since 2011.</li>    <li>It will probably get a different review than our deal,\" he said. \"Power to them if they get it done.</li>    <li>Adding to the hurdles is the fact that Sprint and T-Mobile would be horizontal competitors combining; AT&amp;T has it hands full as it awaits a judge's decision on whether or how it can proceed with a vertical takeover of Time Warner.</li>   <li>Today: <a href='https://seekingalpha.com/symbol/S' title='Sprint Corporation'>S</a> <font color='green'>+1.8%</font>; <a href='https://seekingalpha.com/symbol/TMUS' title='T-Mobile US, Inc.'>TMUS</a> <font color='red'>-0.5%</font>; <a href='https://seekingalpha.com/symbol/T' title='AT&T Inc.'>T</a> <font color='green'>+0.7%</font>; <a href='https://seekingalpha.com/symbol/TWX' title='Time Warner Inc.'>TWX</a> <font color='green'>+0.8%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3360489\" data-linked=\"AT&amp;T&#39;s Stephenson: Sprint/T-Mobile might succeed despite &#39;uphill battle&#39;\" data-tweet=\"$T $T $S - AT&amp;T&#39;s Stephenson: Sprint/T-Mobile might succeed despite &#39;uphill battle&#39; https://seekingalpha.com/news/3360489-ts-stephenson-sprint-t-mobile-might-succeed-despite-uphill-battle?source=tweet\" data-url=\"https://seekingalpha.com/news/3360489-ts-stephenson-sprint-t-mobile-might-succeed-despite-uphill-battle\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>28&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360487\" data-ts=\"1527712002\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VCEL\" target=\"_blank\">VCEL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360487-vericel-readies-stock-offering-shares-down-4-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vericel readies stock offering; shares down 4% after hours</a></h4><ul><li>Vericel (NASDAQ:<a href='https://seekingalpha.com/symbol/VCEL' title='Vericel Corporation'>VCEL</a>) is down&nbsp;<font color='red'>4%</font>&nbsp;after hours on the heels of its announced <a href=\"https://seekingalpha.com/pr/17177890-vericel-corporation-announces-proposed-public-offering-common-stock\" target=\"_blank\">public offering </a>of 3.75M shares of common stock. Underwriters over-allotment is an additional 562.5K shares. Price and terms have yet to be released.</li></ul><div class=\"tiny-share-widget\" data-id=\"3360487\" data-linked=\"Vericel readies stock offering; shares down 4% after hours\" data-tweet=\"$VCEL - Vericel readies stock offering; shares down 4% after hours https://seekingalpha.com/news/3360487-vericel-readies-stock-offering-shares-down-4-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3360487-vericel-readies-stock-offering-shares-down-4-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>35&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360486\" data-ts=\"1527711904\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NGL\" target=\"_blank\">NGL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360486-ngl-energy-partners-to-sell-remaining-propane-business-for-900m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NGL Energy Partners to sell remaining propane business for $900M</a></h4><ul>     <li>NGL Energy Partners (NYSE:<a href='https://seekingalpha.com/symbol/NGL' title='NGL Energy Partners LP'>NGL</a>) <font color='green'>+4.6%</font> after-hours on news it <a href=\"https://seekingalpha.com/pr/17177945-ngl-energy-partners-lp-announces-sale-remaining-retail-propane-business-900-million\" target=\"_blank\">agrees to sell</a> its remaining retail propane business to Superior Plus Corp. for $900M, as it decides to focus on its water solutions and crude logistics businesses.</li><li>NGL says the recent divestitures of all retail propane       assets generated more than $1.1B of gross cash proceeds, which equates       to a 2018 EBITDA multiple exceeding 10x.</li><li>NGL also says the sale will significantly reduce the seasonality and         weather-dependency of its earnings and lower annual maintenance capex by ~$10M.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3360486\" data-linked=\"NGL Energy Partners to sell remaining propane business for $900M\" data-tweet=\"$NGL - NGL Energy Partners to sell remaining propane business for $900M https://seekingalpha.com/news/3360486-ngl-energy-partners-to-sell-remaining-propane-business-for-900m?source=tweet\" data-url=\"https://seekingalpha.com/news/3360486-ngl-energy-partners-to-sell-remaining-propane-business-for-900m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360484\" data-ts=\"1527711738\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GLPG\" target=\"_blank\">GLPG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360484-gilead-and-galapagos-filgotinib-successful-in-mid-stage-psoriatic-arthritis-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gilead and Galapagos&#39; filgotinib successful in mid-stage psoriatic arthritis study</a></h4><ul><li>Galapagos NV (NASDAQ:<a href='https://seekingalpha.com/symbol/GLPG' title='Galapagos'>GLPG</a>) and collaboration partner Gilead Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/GILD' title='Gilead Sciences, Inc.'>GILD</a>) <a href=\"https://seekingalpha.com/pr/17177905-gilead-galapagos-announce-results-filgotinib-phase-2-equator-study-psoriatic-arthritis\" target=\"_blank\">announce positive results</a> from a Phase 2 clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT03101670?titles=equator&amp;spons=galapagos&amp;phase=1&amp;rank=1\" target=\"_blank\">EQUATOR</a>, evaluating JAK1 inhibitor filgotinib in adult patients with moderate-to-severe psoriatic arthritis &#40;PA&#41;.</li><li>The study met the primary endpoint of a statistically significant proportion of patients achieving at least a 20% improvement (ARC20) in signs and symptoms of PA at week 16. Specifically, 80% of patients in the treatment group achieved ARC20 versus 33% for placebo (p&lt;0.001).</li><li>ARC50 (50% improvement in PA symptoms) and ARC70 scores also demonstrated the superiority of filgotinib, 48% vs. 15% (p&lt;0.001) and 23% vs. 6% (p&lt;0.01), respectively.</li><li>No new safety signals were observed. There was one death in the filgotinib group due to pneumonia. Another participant developed herpes zoster (shingles).</li><li>Complete results will be submitted for presentation at a future medical conference.</li><li>Separately, a Phase 2b/3 study, <a href=\"https://clinicaltrials.gov/ct2/show/NCT02914522?titles=selection&amp;spons=galapagos&amp;rank=1\" target=\"_blank\">SELECTION</a>, evaluating filgotinib in ulcerative colitis will proceed into Phase 3 as planned. The action triggers a $15M milestone payment to Galapagos from Gilead.</li><li>The companies are co-developing and co-commercializing filgotinib under a 2015 agreement.</li><li>Gilead is down a fraction after hours while Galapagos is unchanged.</li></ul><div class=\"tiny-share-widget\" data-id=\"3360484\" data-linked=\"Gilead and Galapagos&#39; filgotinib successful in mid-stage psoriatic arthritis study\" data-tweet=\"$GLPG $GLPG $GILD - Gilead and Galapagos&#39; filgotinib successful in mid-stage psoriatic arthritis study https://seekingalpha.com/news/3360484-gilead-and-galapagos-filgotinib-successful-in-mid-stage-psoriatic-arthritis-study?source=tweet\" data-url=\"https://seekingalpha.com/news/3360484-gilead-and-galapagos-filgotinib-successful-in-mid-stage-psoriatic-arthritis-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360483\" data-ts=\"1527711679\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BOX\" target=\"_blank\">BOX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360483-boxminus-3_2-on-q1-beats-mixed-q2-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Box -3.2% on Q1 beats, mixed Q2 guidance</a></h4><ul><li>        Box (NYSE:<a href='https://seekingalpha.com/symbol/BOX' title='Box'>BOX</a>)&nbsp;<font color='red'>drops 3.2%</font>&nbsp;aftermarket on Q1 results that beat EPS and revenue estimates with a 20% Y/Y revenue growth. Mixed Q2 guidance has in-line revenue from $146M to $147M (consensus: $146.24M) and downside EPS from -$0.06 to -$0.05 (-$0.07).</li><li>               In-line FY19 guidance has revenue from $603M to $608M (consensus: $605.69M; was: $602M to $608M) and EPS from -$0.19 to -$0.16 (consensus: -$0.19).&nbsp;</li><li>               Key metrics: Billings, $116.7M (+17%); cash flow from operations, $18.4M (+$9.9M); FCF, $7.3M (+$3.2M). &nbsp;&nbsp;</li><li>               New board member: Sue Barsamian, EVP, Chief Sales and Marketing Officer, with the appointment effective immediately.&nbsp;</li><li>                  Earnings call is scheduled for 5 PM Eastern with a webcast available <a href=\"https://www.boxinvestorrelations.com/home/default.aspx\" target=\"_blank\">here</a>.    </li><li>               <a href=\"https://seekingalpha.com/pr/17177910-box-reports-record-revenue-141-million-delivers-cash-flow-operations-18-million-fiscal-first\" target=\"_blank\">Press release</a>.&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3360462-box-beats-0_01-beats-revenue\" target=\"_blank\">Box beats by $0.01, beats on revenue</a> (May 30)</li></ul><div class=\"tiny-share-widget\" data-id=\"3360483\" data-linked=\"Box -3.2% on Q1 beats, mixed Q2 guidance\" data-tweet=\"$BOX - Box -3.2% on Q1 beats, mixed Q2 guidance https://seekingalpha.com/news/3360483-boxminus-3_2-on-q1-beats-mixed-q2-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3360483-boxminus-3_2-on-q1-beats-mixed-q2-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360479\" data-ts=\"1527711492\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TLYS\" target=\"_blank\">TLYS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360479-calendar-friendly-to-tillys-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Calendar friendly to Tilly&#39;s guidance</a></h4><ul> <li>Tilly's (NYSE:<a href='https://seekingalpha.com/symbol/TLYS' title='Tilly&#39;s, Inc.'>TLYS</a>) soars after posting guidance way ahead of expectations for <a href=\"https://seekingalpha.com/pr/17177930-tilly-s-inc-announces-fiscal-2018-first-quarter-results\" target=\"_blank\">FQ2</a>.</li> <li>The retailer sees Q2 revenue of $153M to $157M vs. $142M consensus and EPS of $0.24 to $0.28 vs. $0.14 consensus.</li> <li>Shares of Tilly's are <font color='green'>up 16%</font> in AH trading, but investors should be careful. Management says that the calendar shift that impacted Q2 guidance in a positive way will come around to ding Q3.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3360479\" data-linked=\"Calendar friendly to Tilly&#39;s guidance\" data-tweet=\"$TLYS - Calendar friendly to Tilly&#39;s guidance https://seekingalpha.com/news/3360479-calendar-friendly-to-tillys-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3360479-calendar-friendly-to-tillys-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360468\" data-ts=\"1527711001\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CARS\" target=\"_blank\">CARS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360468-cars-com-spikes-on-sale-talk\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cars.com spikes on sale talk</a></h4><ul> <li>Cars.com (<a href='https://seekingalpha.com/symbol/CARS' title='Cars.com Inc.'>CARS</a> <font color='green'>+8.9%</font>) made a late day jump after the New York Post <a href=\"https://nypost.com/2018/05/30/cars-com-hires-jpmorgan-to-explore-possible-sale/\" target=\"_blank\">reported</a> that the company hired JPMorgan to advise it on a potential sale.</li> <li>Earlier this month, activist investor Starboard Capital landed two nominees to the board at Cars.com. Sources say Starboard is looking for $40 a share in a sale scenario.</li> <li>Apax Partners and Cox Communications are being talked about as potential bidders for the Cars.com property.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3360468\" data-linked=\"Cars.com spikes on sale talk\" data-tweet=\"$CARS - Cars.com spikes on sale talk https://seekingalpha.com/news/3360468-cars-com-spikes-on-sale-talk?source=tweet\" data-url=\"https://seekingalpha.com/news/3360468-cars-com-spikes-on-sale-talk\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360466\" data-ts=\"1527710955\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KEYS\" target=\"_blank\">KEYS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360466-keysight-eps-in-line-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Keysight EPS in-line, beats on revenue</a></h4><ul><li>Keysight (NYSE:<a href='https://seekingalpha.com/symbol/KEYS' title='Keysight Technologies Inc.'>KEYS</a>): Q2 EPS of $0.83 in-line.</li><li>Revenue of $999M (+31.8% Y/Y) <font color='green'>beats by $38.39M</font>.</li><li>Shares <font color='green'>+4.7%</font>.</li><li><a href='https://seekingalpha.com/pr/17177940-keysight-technologies-reports-second-quarter-2018-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3360466\" data-linked=\"Keysight EPS in-line, beats on revenue\" data-tweet=\"$KEYS - Keysight EPS in-line, beats on revenue https://seekingalpha.com/news/3360466-keysight-eps-in-line-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3360466-keysight-eps-in-line-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:09 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360460\" data-ts=\"1527710545\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SESN\" target=\"_blank\">SESN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360460-sesen-bio-readies-stock-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sesen Bio readies stock offering</a></h4><ul><li>Sesen Bio (NASDAQ:<a href='https://seekingalpha.com/symbol/SESN' title='Sesen Bio, Inc.'>SESN</a>) <a href=\"https://seekingalpha.com/pr/17177888-sesen-bio-announces-proposed-public-offering-common-stock\" target=\"_blank\">launches </a>a public offering of common stock. Price, volume and terms have yet to be announced.</li></ul><div class=\"tiny-share-widget\" data-id=\"3360460\" data-linked=\"Sesen Bio readies stock offering\" data-tweet=\"$SESN - Sesen Bio readies stock offering https://seekingalpha.com/news/3360460-sesen-bio-readies-stock-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3360460-sesen-bio-readies-stock-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360456\" data-ts=\"1527710187\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SC\" target=\"_blank\">SC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360456-santander-consumer-stock-descent-is-overdone-says-btig-analyst\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Santander Consumer stock descent is overdone,&quot; says BTIG analyst</a></h4><ul><li>Santander Consumer USA (NYSE:<a href='https://seekingalpha.com/symbol/SC' title='Santander Consumer USA Holdings Inc'>SC</a>), down 6.3% in late trading, pared an earlier loss of more than 9% today after Bloomberg reported that Fiat Chrysler (NYSE:<a href='https://seekingalpha.com/symbol/FCAU' title='Fiat Chrysler Automobiles NV'>FCAU</a>) is likely to set up its own U.S. finance unit, an action that would \"introduce and element of uncertainty into the SC story,\" BTIG analyst Mark Palmer wrote in a <a href=\"http://researchwiseny.btig.com/ResearchLibraryAnalec/DownloadResearch.aspx?E=bcjjek-b\" target=\"_blank\">note</a>.</li><li>Still, Palmer sees the market reaction as \"overdone\" and says investors should instead focus on SC's excess capital and the potential for its parent to buy out the remaining shares that it doesn't already own.</li><li>He reiterates his \"buy\" recommendation on price target of $21.</li><li>The 10-year financing agreement with Fiat Chrysler has been disappointing to both parties. The arrangement's targeted penetration rate as of April 30 was 65%, while SC's actual penetration rate for Chrysler Capital during Q118 was 28%, Palmer says.</li><li>If Fiat Chrysler's action does lead to lower volume for SC, the company could be willing to accept a smaller balance sheet and focus on share buybacks, which \" could result in more upside for shareholders within a shorter period of time,\" Palmer notes.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3360417-santander-consumer-nearly-10-percent-fiat-revamp\" target=\"_blank\">Santander Consumer down nearly 10% on Fiat revamp</a> (May 30)</li></ul><div class=\"tiny-share-widget\" data-id=\"3360456\" data-linked=\"Santander Consumer stock descent is overdone,&quot; says BTIG analyst\" data-tweet=\"$SC $SC $FCAU - Santander Consumer stock descent is overdone,&quot; says BTIG analyst https://seekingalpha.com/news/3360456-santander-consumer-stock-descent-is-overdone-says-btig-analyst?source=tweet\" data-url=\"https://seekingalpha.com/news/3360456-santander-consumer-stock-descent-is-overdone-says-btig-analyst\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:56 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360452\" data-ts=\"1527709686\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOGO\" target=\"_blank\">GOGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360452-director-townsend-snapping-up-gogo-shares-amid-decline\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Director Townsend snapping up Gogo shares amid decline</a></h4><ul>   <li>Shares in Gogo (<a href=\"http://seekingalpha.com/symbol/GOGO\" target=\"_blank\">GOGO</a> <font color='red'>-5.7%</font>) have hit their all-time low today after a <a href=\"https://seekingalpha.com/news/3360340-gogo-slides-8_8-percent-morgan-stanley-frets-funding\" target=\"_blank\">price-target slashing from Morgan Stanley</a>, though one director is taking advantage of a post-earnings decline this week.</li>    <li>In filings over the past 24 hours, Charles Townsend has disclosed that he purchased a <a href=\"https://seekingalpha.com/filing/4043555\" target=\"_blank\">combined 359,267 shares</a> last Thursday and Friday (for just under a combined $1.79M), for direct holding by PAC LLC.</li>    <li>Yesterday, he <a href=\"https://seekingalpha.com/filing/4045747\" target=\"_blank\">acquired another 140,733 shares</a> for PAC LLC for just under $740,000.</li>    <li>Townsend owns another 554,267 shares through a trust. PAC LLC holds 2,120,344 shares after the transactions.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3360452\" data-linked=\"Director Townsend snapping up Gogo shares amid decline\" data-tweet=\"$GOGO - Director Townsend snapping up Gogo shares amid decline https://seekingalpha.com/news/3360452-director-townsend-snapping-up-gogo-shares-amid-decline?source=tweet\" data-url=\"https://seekingalpha.com/news/3360452-director-townsend-snapping-up-gogo-shares-amid-decline\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360449\" data-ts=\"1527708711\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATI\" target=\"_blank\">ATI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360449-allegheny-techplus-5-goldman-upgrades-ak-steel-up-despite-sell-rating\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Allegheny Tech +5% as Goldman upgrades; AK Steel up despite Sell rating</a></h4><ul>     <li>Allegheny Technologies (<a href='https://seekingalpha.com/symbol/ATI' title='Allegheny Technologies Incorporated'>ATI</a> <font color='green'>+4.7%</font>) enjoys strong gains after Goldman Sachs analyst Matthew Korn <a href=\"https://www.barrons.com/articles/goldman-sachs-three-steel-stocks-to-buy-one-to-avoid-1527694035?mod=hp_RTA\" target=\"_blank\">upgrades</a> shares to Neutral from Sell with a $29 price target, raised from $26, citing the company's \"consistency in a growing but technologically challenging market\" as well as fair valuation.</li>     <li>AK&nbsp;Steel (<a href='https://seekingalpha.com/symbol/AKS' title='AK Steel Holding Corp'>AKS</a> <font color='green'>+3.7%</font>) also is higher even as Goldman <a href=\"https://seekingalpha.com/news/3360284-ak-steel-minus-2-percent-goldman-cuts-sell-4-price-target\" target=\"_blank\">cuts shares to Sell</a>, saying \"unfavorable trends\" in its realized prices are an ongoing overhang for the company and require more conservative margin projections.</li>     <li>Korn also rates Nucor (<a href='https://seekingalpha.com/symbol/NUE' title='Nucor Corporation'>NUE</a> <font color='green'>+2.2%</font>) and Steel Dynamics (<a href='https://seekingalpha.com/symbol/STLD' title='Steel Dynamics, Inc.'>STLD</a> <font color='green'>+2.8%</font>) as Buys, saying the stocks \"offer a clearer path toward growth and expanded profitability.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3360449\" data-linked=\"Allegheny Tech +5% as Goldman upgrades; AK Steel up despite Sell rating\" data-tweet=\"$ATI $ATI $AKS - Allegheny Tech +5% as Goldman upgrades; AK Steel up despite Sell rating https://seekingalpha.com/news/3360449-allegheny-techplus-5-goldman-upgrades-ak-steel-up-despite-sell-rating?source=tweet\" data-url=\"https://seekingalpha.com/news/3360449-allegheny-techplus-5-goldman-upgrades-ak-steel-up-despite-sell-rating\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360441\" data-ts=\"1527707566\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ROLL\" target=\"_blank\">ROLL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360441-rbc-bearings-up-2-post-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RBC Bearings up 2% post Q4 results</a></h4><ul><li>RBC Bearings (<a href='https://seekingalpha.com/symbol/ROLL' title='RBC Bearings Incorporated'>ROLL</a> <font color='green'>+2.3%</font>)&nbsp;<u><a href=\"https://seekingalpha.com/filing/4045205\" target=\"_blank\">reports Q4</a></u> revenue growth of 12.3% Y/Y      to $179.9M.</li><li>Organic net sales growth of 13.5% in Q4 &amp; 10.0% for full      year 2018.</li><li>Segment net external sales: Plain bearings $81.9M (+12.8% Y/Y); Roller bearings $35.8M      (+24.7% Y/Y); Ball bearings $19.1M (+15.8% Y/Y) &amp; Engineered products $43.1M (+1.4% Y/Y).</li><li>Q1      overall margins: Adj. gross&nbsp;<font color='red'>declined 70 bps</font>&nbsp;to 38.8%; adj. operating&nbsp;<font color='red'>declined 20 bps</font>&nbsp;to 21.3% .</li><li>Backlog      was $392.1M (+10.7% Y/Y).</li><li>CFO was $37.8M (+41.6% Y/Y); Capex of $7.4M (+13.8%      Y/Y); Total debt $173.4M (-35.7% Y/Y) &amp; Cash and short-term      investments of $54.2M (+39.3% Y/Y).</li><li><b>Q1      Outlook: </b>Net      sales ~$171-174M, will result in a growth rate of ~4.3%-6.2% Y/Y &amp;      organic growth rate of ~6.3%-8.2% Y/Y.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3360231-rbc-bearings-misses-0_06-beats-revenue\" target=\"_blank\">RBC Bearings misses by $0.06, beats on revenue</a> (May 30)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3360441\" data-linked=\"RBC Bearings up 2% post Q4 results\" data-tweet=\"$ROLL - RBC Bearings up 2% post Q4 results https://seekingalpha.com/news/3360441-rbc-bearings-up-2-post-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3360441-rbc-bearings-up-2-post-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:12 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360442\" data-ts=\"1527707535\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BJRI\" target=\"_blank\">BJRI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360442-bjs-restaurantsplus-6-on-guggenheim-confidence\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BJ&#39;s Restaurants +6% on Guggenheim confidence</a></h4><ul> <li>Shares of BJ's Restaurants (NASDAQ:<a href='https://seekingalpha.com/symbol/BJRI' title='BJ&#39;s Restaurants, Inc.'>BJRI</a>) are <font color='green'>up 6.15%</font> after Guggenheim lifts its price target on the Buy-rated restaurant stock to $62 from $55.</li> <li>The $62 PT matches the highest on the books of a Wall Street firm and is above the 52-week high on BJRI of $57.65.</li> <li>Sources: MarketWatch, Bloomberg</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3360442\" data-linked=\"BJ&#39;s Restaurants +6% on Guggenheim confidence\" data-tweet=\"$BJRI - BJ&#39;s Restaurants +6% on Guggenheim confidence https://seekingalpha.com/news/3360442-bjs-restaurantsplus-6-on-guggenheim-confidence?source=tweet\" data-url=\"https://seekingalpha.com/news/3360442-bjs-restaurantsplus-6-on-guggenheim-confidence\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:12 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360437\" data-ts=\"1527706506\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SGLB\" target=\"_blank\">SGLB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360437-technology-top-5-gainers-losers-of-2_55-pm-05-30-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers as of 2.55 PM (05/30/2018)</a></h4><ul>     <li><strong>Gainers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/SGLB' title='Sigma Labs, Inc.'>SGLB</a> <font color='green'>+104%</font>. <a href='https://seekingalpha.com/symbol/PDVW' title='pdvWireless, Inc.'>PDVW</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/APPS' title='Digital Turbine, Inc.'>APPS</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/IQ' title='iQIYI, Inc'>IQ</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/BITA' title='Bitauto Holdings Limited'>BITA</a> <font color='green'>+11%</font>.</li>      <li><strong>Losers:</strong> <a href='https://seekingalpha.com/symbol/DAKT' title='Daktronics, Inc.'>DAKT</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/WIN' title='Windstream Holdings, Inc.'>WIN</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/LFIN' title='LongFin Corp.A'>OTCPK:LFIN</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/DQ' title='DAQO New Energy Corp.'>DQ</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/COHR' title='Coherent, Inc.'>COHR</a> <font color='red'>-7%</font>.</li>     &nbsp; </ul><div class=\"tiny-share-widget\" data-id=\"3360437\" data-linked=\"Technology - Top 5 Gainers / Losers as of 2.55 PM (05/30/2018)\" data-tweet=\"$SGLB $SGLB $ATEX - Technology - Top 5 Gainers / Losers as of 2.55 PM (05/30/2018) https://seekingalpha.com/news/3360437-technology-top-5-gainers-losers-of-2_55-pm-05-30-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3360437-technology-top-5-gainers-losers-of-2_55-pm-05-30-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360432\" data-ts=\"1527705179\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CP\" target=\"_blank\">CP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360432-cp-rail-strike-ends-after-reaching-deal-conductors-engineers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CP Rail strike ends after reaching deal with conductors, engineers</a></h4><ul>     <li>Canadian Pacific Railway (<a href='https://seekingalpha.com/symbol/CP' title='Canadian Pacific Railway Limited'>CP</a> <font color='green'>+3.2%</font>) says it <a href=\"https://seekingalpha.com/pr/17177771-tcrc-t-and-e-cp-reach-tentative-four-year-agreement\" target=\"_blank\">reached tentative agreements</a> with ~3K conductors and locomotive engineers, ending a strike hours after it began.</li>     <li>\"This is a positive result for our TCRC employees and their families, the 12,000-strong CP family, our customers and the entire Canadian economy,\" says CP&nbsp;Rail President and CEO Keith Creel.</li>     <li>The company <a href=\"https://seekingalpha.com/news/3360256-cp-rail-train-operators-begin-strike-signal-workers-reach-deal\" target=\"_blank\">earlier</a> reached a deal with ~360 signal workers.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3360432\" data-linked=\"CP Rail strike ends after reaching deal with conductors, engineers\" data-tweet=\"$CP - CP Rail strike ends after reaching deal with conductors, engineers https://seekingalpha.com/news/3360432-cp-rail-strike-ends-after-reaching-deal-conductors-engineers?source=tweet\" data-url=\"https://seekingalpha.com/news/3360432-cp-rail-strike-ends-after-reaching-deal-conductors-engineers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360431\" data-ts=\"1527704542\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CVX\" target=\"_blank\">CVX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360431-chevron-shareholders-turn-aside-climate-methane-proposals\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chevron shareholders turn aside climate, methane proposals</a></h4><ul><li>Chevron (<a href='https://seekingalpha.com/symbol/CVX' title='Chevron Corporation'>CVX</a> <font color='green'>+3.3%</font>) <a href=\"https://www.axios.com/climate-methane-votes-fail-at-chevron-shareholder-meeting-9a029c8c-b891-44a6-8de4-003e2f72fdc2.html\" target=\"_blank\">shareholders reject</a> two non-binding but symbolically important  shareholder resolutions related to climate change at the company&rsquo;s annual  meeting, but a measure calling for more action to cut methane emissions narrowly lost with 45% support.</li><li>The close call could prompt CVX to follow Exxon's move last year in implementing a methane management program and setting a reduction target.</li><li>Another more aggressive proposal calling for CVX to propose  ways to reduce its production of fossil fuels received just 8% of shareholder votes.</li><li>CVX shares, like XOM, are surging today as <a href=\"https://seekingalpha.com/news/3360361-oil-shoots-higher-report-opec-will-maintain-production-curbs\" target=\"_blank\">crude oil prices spike</a> following a report that OPEC and other top oil producing countries may leave current production curbs in place.</li></ul><div class=\"tiny-share-widget\" data-id=\"3360431\" data-linked=\"Chevron shareholders turn aside climate, methane proposals\" data-tweet=\"$CVX - Chevron shareholders turn aside climate, methane proposals https://seekingalpha.com/news/3360431-chevron-shareholders-turn-aside-climate-methane-proposals?source=tweet\" data-url=\"https://seekingalpha.com/news/3360431-chevron-shareholders-turn-aside-climate-methane-proposals\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360429\" data-ts=\"1527704401\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MRKR\" target=\"_blank\">MRKR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360429-tapimmune-up-24\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TapImmune up 24%</a></h4><ul><li>Thinly traded nano cap TapImmune (TPIV <font color='green'>+24.4%</font>) is up on a 23x surge in volume. No particular news accounts for the action although the company is in need of additional capital.</li><li>At the end of March, it has <a href=\"https://www.sec.gov/Archives/edgar/data/1094038/000114420418028862/tv493258_10q.htm#a_003\" target=\"_blank\">$2.8M in cash</a> while operations consumed ~$2.3M in Q1.</li><li>In late December 2017, it filed a <a href=\"https://www.sec.gov/Archives/edgar/data/1094038/000114420417065906/tv482341_424b3.htm\" target=\"_blank\">prospectus </a>for the potential resale of ~4.4M common shares by existing investors and ~6.5M shares issuable upon the exercise of warrants.</li></ul><div class=\"tiny-share-widget\" data-id=\"3360429\" data-linked=\"TapImmune up 24%\" data-tweet=\"$MRKR - TapImmune up 24% https://seekingalpha.com/news/3360429-tapimmune-up-24?source=tweet\" data-url=\"https://seekingalpha.com/news/3360429-tapimmune-up-24\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360424\" data-ts=\"1527703242\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLD\" target=\"_blank\">CLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360424-energy-materials-top-gainers-losers-of-2-00-pm-05-30-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 PM (05/30/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CLD' title='Cloud Peak Energy, Inc.'>CLD</a> <font color='green'>+23%</font>. <a href='https://seekingalpha.com/symbol/LGCY' title='Legacy Reserves Inc'>LGCY</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/LGCYO' title='Legacy Reserves LP Cum Red Perp Pfd Units Series B'>LGCYO</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/LGCYP' title='Legacy Reserves LP Cum Red Perp Pfd Units Series A'>LGCYP</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/SN' title='Sanchez Energy Corporation'>SN</a> <font color='green'>+10%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/GBR' title='New Concept Energy, Inc.'>GBR</a> <font color='red'>-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3360424\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 PM (05/30/2018)\" data-tweet=\"$CLD $CLDPQ $LGCY - Energy/Materials - Top Gainers / Losers as of 2:00 PM (05/30/2018) https://seekingalpha.com/news/3360424-energy-materials-top-gainers-losers-of-2-00-pm-05-30-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3360424-energy-materials-top-gainers-losers-of-2-00-pm-05-30-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360417\" data-ts=\"1527701713\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SC\" target=\"_blank\">SC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360417-santander-consumer-down-nearly-10-on-fiat-revamp\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Santander Consumer down nearly 10% on Fiat revamp</a></h4><ul><li>Fiat Chrysler<a href=\"https://seekingalpha.com/news/3360328-major-strategy-reset-tap-fiat\" target=\"_blank\"> is reportedly mulling </a>no longer selling Fiat brand autos in the U.S. and China, and is also considering starting its own finance unit (for Chrysler) in the U.S.</li><li>Santander Consumer (<a href='https://seekingalpha.com/symbol/SC' title='Santander Consumer USA Holdings Inc'>SC</a> <font color='red'>-8%</font>) is most exposed to Chrysler. Also of interest to Ally Financial (<a href='https://seekingalpha.com/symbol/ALLY' title='Ally Financial Inc.'>ALLY</a> <font color='red'>-2.6%</font>) and Credit Acceptance (<a href='https://seekingalpha.com/symbol/CACC' title='Credit Acceptance Corporation'>CACC</a> <font color='green'>+1.4%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3360417\" data-linked=\"Santander Consumer down nearly 10% on Fiat revamp\" data-tweet=\"$SC $SC $ALLY - Santander Consumer down nearly 10% on Fiat revamp https://seekingalpha.com/news/3360417-santander-consumer-down-nearly-10-on-fiat-revamp?source=tweet\" data-url=\"https://seekingalpha.com/news/3360417-santander-consumer-down-nearly-10-on-fiat-revamp\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360412\" data-ts=\"1527701101\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ORMP\" target=\"_blank\">ORMP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360412-oramed-up-20-on-u-s-patent-for-pod-technology\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oramed up 20% on U.S. patent for POD technology</a></h4><ul><li>Thinly traded micro cap Oramed Pharmaceuticals (<a href='https://seekingalpha.com/symbol/ORMP' title='Oramed Pharmaceuticals Inc.'>ORMP</a> <font color='green'>+20.3%</font>) is up on almost a 5x surge in volume, albeit on turnover of only 86K shares, in apparent response to its <a href=\"https://seekingalpha.com/pr/17177065-oramed-patent-allowed-us-oral-administration-proteins\" target=\"_blank\">announcement </a>of the issuance of a new U.S. patent covering methods and compositions for the oral administration of proteins. The patent provides additional protection for its POD technology used in its oral insulin.</li></ul><div class=\"tiny-share-widget\" data-id=\"3360412\" data-linked=\"Oramed up 20% on U.S. patent for POD technology\" data-tweet=\"$ORMP - Oramed up 20% on U.S. patent for POD technology https://seekingalpha.com/news/3360412-oramed-up-20-on-u-s-patent-for-pod-technology?source=tweet\" data-url=\"https://seekingalpha.com/news/3360412-oramed-up-20-on-u-s-patent-for-pod-technology\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360397\" data-ts=\"1527700435\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DAKT\" target=\"_blank\">DAKT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360397-daktronics-down-17-on-q4-earnings-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Daktronics down 17% on Q4 earnings miss</a></h4><ul><li>Daktronics (<a href='https://seekingalpha.com/symbol/DAKT' title='Daktronics, Inc.'>DAKT</a> <font color='red'>-17.5%</font>) reported Q4 net sales of $138.18M (-3.8% Y/Y) and total orders of $161.97M (-9.1% Y/Y).</li><li>Segment sales: Commercial $31.81M (-11% Y/Y), live events $44.9M (-21.1% Y/Y), high school park &amp; recreation $18.03M (+30.4% Y/Y), transportation $13M (+0.7% Y/Y) and international $30.44M (+25.4% Y/Y).</li><li>Segment orders: Commercial $37.55M (+0.8% Y/Y), live events $55.79M (-33.9% Y/Y), high school park &amp; recreation $26.85M (+19.2% Y/Y), transportation $12.43M (-24% Y/Y) and international $27.34M (+87.6% Y/Y).</li><li>Q4 Overall margins: gross&nbsp;<font color='red'>declined by 187 bps</font>&nbsp;to 21.6% and operating&nbsp;<font color='red'>declined by 507 bps</font>&nbsp;to -3.88%.</li><li>Q4 Expenses: Selling increased by 7.8% Y/Y to $17.2M, G&amp;A increased by 6.4% Y/Y to $8.78M and product design &amp; development increased by14.04% Y/Y to $9.23M.</li><li>Cash flow from operating activities was $30.4M as of 28 April 2018, down 29.6% Y/Y.</li><li>Backlog was $171M as of 28 April 2018, a decline of 18.71% Y/Y from $203M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3360220-daktronics-misses-0_14-misses-revenue\" target=\"_blank\">Daktronics misses by $0.14, misses on revenue</a> (May 30)</li></ul><div class=\"tiny-share-widget\" data-id=\"3360397\" data-linked=\"Daktronics down 17% on Q4 earnings miss\" data-tweet=\"$DAKT - Daktronics down 17% on Q4 earnings miss https://seekingalpha.com/news/3360397-daktronics-down-17-on-q4-earnings-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/3360397-daktronics-down-17-on-q4-earnings-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:13 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360407\" data-ts=\"1527700228\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSRO\" target=\"_blank\">TSRO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360407-parp-players-tesarominus-8-and-clovisminus-3-underwater-mid-session\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PARP players TESARO (-8%) and Clovis (-3%) underwater mid-session</a></h4><ul><li>TESARO (<a href='https://seekingalpha.com/symbol/TSRO' title='Tesaro'>TSRO</a> <font color='red'>-8.4%</font>) and PARP inhibitor competitor Clovis Oncology (<a href='https://seekingalpha.com/symbol/CLVS' title='Clovis Oncology'>CLVS</a> <font color='red'>-2.9%</font>) are both in the red, but the former's drop is on 55% higher volume.</li><li>No particular news accounts for the action. Yesterday, Jim Cramer gave Clovis a thumbs down during his <a href=\"https://www.cnbc.com/video/2018/05/29/cramers-lightening-round-buy-undervalued-groupon.html\" target=\"_blank\">Lightning Round</a> segment, though his reasons were generic to biotechs (losing lots of money, speculative).</li></ul><div class=\"tiny-share-widget\" data-id=\"3360407\" data-linked=\"PARP players TESARO (-8%) and Clovis (-3%) underwater mid-session\" data-tweet=\"$TSRO $TSRO $CLVS - PARP players TESARO (-8%) and Clovis (-3%) underwater mid-session https://seekingalpha.com/news/3360407-parp-players-tesarominus-8-and-clovisminus-3-underwater-mid-session?source=tweet\" data-url=\"https://seekingalpha.com/news/3360407-parp-players-tesarominus-8-and-clovisminus-3-underwater-mid-session\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360404\" data-ts=\"1527699753\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WIN\" target=\"_blank\">WIN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360404-windstream-reportedly-seeking-credit-amendment-sharesminus-13_3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Windstream reportedly seeking credit amendment; shares -13.3%</a></h4><ul>   <li>Windstream Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/WIN' title='Windstream Holdings, Inc.'>WIN</a>) is <font color='red'>off 13.3%</font> today following word that its Windstream Services unit is looking for an amendment to its credit facility.</li>    <li>There's a lender call set for 4 p.m. ET today, Bloomberg reports, to address an amendment to its $1.25B revolving credit facility, a $1.19B term loan B-7 and $573M term loan B-7 to allow second-lien capacity among other changes.</li>    <li>Consents are due June 5, Bloomberg says.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3360404\" data-linked=\"Windstream reportedly seeking credit amendment; shares -13.3%\" data-tweet=\"$WIN $WINMQ - Windstream reportedly seeking credit amendment; shares -13.3% https://seekingalpha.com/news/3360404-windstream-reportedly-seeking-credit-amendment-sharesminus-13_3?source=tweet\" data-url=\"https://seekingalpha.com/news/3360404-windstream-reportedly-seeking-credit-amendment-sharesminus-13_3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360400\" data-ts=\"1527699654\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YRIV\" target=\"_blank\">YRIV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360400-financials-top-gainers-losers-of-1-00-pm-05-30-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top Gainers / Losers as of 1:00 PM (05/30/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/YRIV' title='Yangtze River Port and Logistics Limited'>YRIV</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/HDB' title='HDFC Bank Limited'>HDB</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/CBL' title='CBL & Associates Properties, Inc.'>CBL</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/TRMT' title='Tremont Mortgage Trust'>TRMT</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/GNW' title='Genworth Financial, Inc.'>GNW</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/IHT' title='Innsuites Hospitality Trust'>IHT</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/LEJU' title='Leju Holdings Limited'>LEJU</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/SC' title='Santander Consumer USA Holdings Inc'>SC</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3360400\" data-linked=\"Financials - Top Gainers / Losers as of 1:00 PM (05/30/2018)\" data-tweet=\"$YRIV $YRIV $HDB - Financials - Top Gainers / Losers as of 1:00 PM (05/30/2018) https://seekingalpha.com/news/3360400-financials-top-gainers-losers-of-1-00-pm-05-30-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3360400-financials-top-gainers-losers-of-1-00-pm-05-30-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360398\" data-ts=\"1527699396\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360398-stocks-retake-lost-ground-led-surging-energy-sector\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stocks retake lost ground, led by surging energy sector</a></h4><ul><li>Three hours before the close, the major averages are near session highs, the Dow and S&amp;P 500&nbsp;<font color='green'>up 1.15%</font>, and the Nasdaq&nbsp;<font color='green'>0.8%</font>.</li><li>The energy sector leads gains,&nbsp;<font color='green'>ahead 3%&nbsp;</font>on a big jump oil prices <a href=\"https://seekingalpha.com/news/3360361-oil-shoots-higher-report-opec-will-maintain-production-curbs\" target=\"_blank\">as Reuters reports</a> OPEC's current production agreement as staying in place until year-end.</li></ul><div class=\"tiny-share-widget\" data-id=\"3360398\" data-linked=\"Stocks retake lost ground, led by surging energy sector\" data-tweet=\"Stocks retake lost ground, led by surging energy sector https://seekingalpha.com/news/3360398-stocks-retake-lost-ground-led-surging-energy-sector?source=tweet\" data-url=\"https://seekingalpha.com/news/3360398-stocks-retake-lost-ground-led-surging-energy-sector\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:56 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360394\" data-ts=\"1527698931\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XOM\" target=\"_blank\">XOM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360394-exxon-shareholders-nix-proposal-to-split-chairman-ceo-roles\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Exxon shareholders nix proposal to split chairman, CEO roles</a></h4><ul><li>Exxon Mobil (<a href='https://seekingalpha.com/symbol/XOM' title='Exxon Mobil Corporation'>XOM</a> <font color='green'>+3.6%</font>) <a href=\"https://www.reuters.com/article/us-exxon-mobil-agm/exxon-shareholders-reject-proposal-to-split-ceo-chair-roles-idUSKCN1IV24L\" target=\"_blank\">shareholders reject</a> a proposal that  would have split the roles of chairman and CEO, securing Darren Woods&rsquo;s position alone at the top of the company hierarchy.</li><li>Shareholders also rejected a proposal that would have forced XOM to  provide greater disclosure on its lobbying expenditures and approved a full slate of 10 nominees to the company&rsquo;s board.</li><li>No climate-related proposals were on the agenda for this year&rsquo;s meeting after a requirement for an annual carbon report was approved last year.</li><li>XOM shares are surging today on the heels of a <a href=\"https://seekingalpha.com/news/3360361-oil-shoots-higher-report-opec-will-maintain-production-curbs\" target=\"_blank\">spike in crude oil prices</a> and an <a href=\"https://seekingalpha.com/news/3360326-exxon-plus-2-percent-rbc-upgrades-foreseeing-substantial-dividend-growth\" target=\"_blank\">analyst upgrade</a> from RBC Capital.</li></ul><div class=\"tiny-share-widget\" data-id=\"3360394\" data-linked=\"Exxon shareholders nix proposal to split chairman, CEO roles\" data-tweet=\"$XOM - Exxon shareholders nix proposal to split chairman, CEO roles https://seekingalpha.com/news/3360394-exxon-shareholders-nix-proposal-to-split-chairman-ceo-roles?source=tweet\" data-url=\"https://seekingalpha.com/news/3360394-exxon-shareholders-nix-proposal-to-split-chairman-ceo-roles\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360393\" data-ts=\"1527698828\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PFE\" target=\"_blank\">PFE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360393-fda-oks-pfizers-xeljanz-for-ulcerative-colitis-shares-up-1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA OKs Pfizer&#39;s Xeljanz for ulcerative colitis; shares up 1%</a></h4><ul><li>The FDA <a href=\"https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm609225.htm\" target=\"_blank\">approves </a>Pfizer's (<a href='https://seekingalpha.com/symbol/PFE' title='Pfizer Inc.'>PFE</a> <font color='green'>+1%</font>) <a href=\"http://ra.xeljanz.com/\" target=\"_blank\">XELJANZ </a>( tofacitinib) for the treatment of moderately-to-severely active ulcerative colitis.</li><li>The JAK inhibitor was approved in the U.S. in 2012 for rheumatoid arthritis and in 2017 for psoriatic arthritis.</li></ul><div class=\"tiny-share-widget\" data-id=\"3360393\" data-linked=\"FDA OKs Pfizer&#39;s Xeljanz for ulcerative colitis; shares up 1%\" data-tweet=\"$PFE - FDA OKs Pfizer&#39;s Xeljanz for ulcerative colitis; shares up 1% https://seekingalpha.com/news/3360393-fda-oks-pfizers-xeljanz-for-ulcerative-colitis-shares-up-1?source=tweet\" data-url=\"https://seekingalpha.com/news/3360393-fda-oks-pfizers-xeljanz-for-ulcerative-colitis-shares-up-1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360390\" data-ts=\"1527698246\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SGLB\" target=\"_blank\">SGLB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360390-midday-gainers-losers-05-30-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers (05/30/2018)</a></h4><ul>     <li><strong>Gainers:</strong> <a href='https://seekingalpha.com/symbol/SGLB' title='Sigma Labs, Inc.'>SGLB</a> <font color='green'>+93%</font>. <a href='https://seekingalpha.com/symbol/OGEN' title='Oragenics, Inc.'>OGEN</a> <font color='green'>+77%</font>. <a href='https://seekingalpha.com/symbol/DKS' title='Dick&#39;s Sporting Goods, Inc.'>DKS</a> <font color='green'>+27%</font>. <a href='https://seekingalpha.com/symbol/SPTN' title='SpartanNash Company'>SPTN</a> <font color='green'>+20%</font>. TPIV <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/CREG' title='China Recycling Energy Corporation'>CREG</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/ORMP' title='Oramed Pharmaceuticals Inc.'>ORMP</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/MOV' title='Movado Group, Inc.'>MOV</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/APPS' title='Digital Turbine, Inc.'>APPS</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/CLD' title='Cloud Peak Energy, Inc.'>CLD</a> <font color='green'>+13%</font>.</li>     <li><strong>Losers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/CHS' title='Chico&#39;s FAS, Inc.'>CHS</a> <font color='red'>-21%</font>. <a href='https://seekingalpha.com/symbol/DAKT' title='Daktronics, Inc.'>DAKT</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/WIN' title='Windstream Holdings, Inc.'>WIN</a> <font color='red'>-13%</font>. KORS <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/IHT' title='Innsuites Hospitality Trust'>IHT</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/CHCI' title='Comstock Homebuilding Companies, Inc.'>CHCI</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/DQ' title='DAQO New Energy Corp.'>DQ</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/AVGR' title='Avinger'>AVGR</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/LEJU' title='Leju Holdings Limited'>LEJU</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/LFIN' title='LongFin Corp.A'>OTCPK:LFIN</a> <font color='red'>-8%</font>.</li>      &nbsp; </ul><div class=\"tiny-share-widget\" data-id=\"3360390\" data-linked=\"Midday Gainers / Losers (05/30/2018)\" data-tweet=\"$SGLB $SGLB $OGEN - Midday Gainers / Losers (05/30/2018) https://seekingalpha.com/news/3360390-midday-gainers-losers-05-30-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3360390-midday-gainers-losers-05-30-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360388\" data-ts=\"1527698042\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BLNK\" target=\"_blank\">BLNK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360388-blink-charging-tracks-higher\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Blink Charging tracks higher</a></h4><ul> <li>Blink Charging (NASDAQ:<a href='https://seekingalpha.com/symbol/BLNK' title='Blink Charging Co.'>BLNK</a>) is <font color='green'>up 7.25%</font> on volume of over 2.8M shares.</li> <li>Last week, the company said the $15M it raised through the issuance of warrants will be used to fund growth and expand into more EV markets.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3360388\" data-linked=\"Blink Charging tracks higher\" data-tweet=\"$BLNK - Blink Charging tracks higher https://seekingalpha.com/news/3360388-blink-charging-tracks-higher?source=tweet\" data-url=\"https://seekingalpha.com/news/3360388-blink-charging-tracks-higher\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:34 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360362\" data-ts=\"1527696211\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMCO\" target=\"_blank\">CMCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360362-columbus-mckinnon-jumps-8-on-q4-earnings-good-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Columbus McKinnon jumps 8% on Q4 earnings, good guidance</a></h4><ul><li>Columbus McKinnon (<a href='https://seekingalpha.com/symbol/CMCO' title='Columbus McKinnon Corporation'>CMCO</a> <font color='green'>+8.6%</font>) reported Q4 net sales growth of 16.6% to $214.14M, US sales were $111.8M (+7.3% Y/Y) and Non-US sales were $102.3M (+28.7% Y/Y).</li><li>Q4 overall margins: Gross&nbsp;<font color='green'>improved 740 bps</font>&nbsp;to 34.8%, adj. gross&nbsp;<font color='green'>improved by 240 bps</font>&nbsp;to 34.6%, operating&nbsp;<font color='green'>recovered by 930 bps&nbsp;</font>to 7.6%, adj. operating&nbsp;<font color='green'>improved 40 bps</font>&nbsp;to 9.6% and Adj. EBITDA&nbsp;<font color='green'>improved by 60 bps&nbsp;</font>to 13.9%.</li><li>Q4 expenses margins: Selling increased by 120 bps to 12.9% and G&amp;A decreased by 300 bps to 10.7%.</li><li>Backlog was $177.4M as of 31 March 2018, up 16% from $152.3M 31 as on December 2017.</li><li>Company paid $60.1M of debt, reducing the net debt to $363.3M as of 31 March 2018.</li><li>US shipping days were 63 in FY18 compared to 64 in FY17.</li><li>1Q19 Outlook: Revenue growth between 7-9% (including benefits from forex); SG&amp;A expenses of ~$48M, additional $0.5M in savings and ~$2M in restructuring cost.</li><li>FY19 Outlook: Capex $15-20M and tax rate 21-23%</li><li>Previously: <a href=\"https://seekingalpha.com/news/3360183-columbus-mckinnon-beats-0_02-beats-revenue\" target=\"_blank\">Columbus McKinnon beats by $0.02, beats on revenue</a> (May 30)</li><li><a href=\"https://seekingalpha.com/article/4178089-columbus-mckinnon-corporation-2018-q4-results-earnings-call-slides\" target=\"_blank\">Slides</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3360362\" data-linked=\"Columbus McKinnon jumps 8% on Q4 earnings, good guidance\" data-tweet=\"$CMCO - Columbus McKinnon jumps 8% on Q4 earnings, good guidance https://seekingalpha.com/news/3360362-columbus-mckinnon-jumps-8-on-q4-earnings-good-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3360362-columbus-mckinnon-jumps-8-on-q4-earnings-good-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:03 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360380\" data-ts=\"1527696053\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MOV\" target=\"_blank\">MOV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360380-consumer-top-5-gainers-losers-of-12-00-pm-05-30-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top 5 Gainers / Losers as of 12:00 PM (05/30/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/MOV' title='Movado Group, Inc.'>MOV</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/KOSS' title='Koss Corporation'>KOSS</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/CLXT' title='Calyxt, Inc.'>CLXT</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/FCAU' title='Fiat Chrysler Automobiles NV'>FCAU</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/CELH' title='Celsius Holdings, Inc.'>CELH</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> KORS <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/CTIB' title='CTI Industries Corporation'>CTIB</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/LBIX-OLD' title='Leading Brands Inc'>LBIX-OLD</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/WILC' title='G. Willi-Food International, Ltd.'>WILC</a> <font color='red'>-5%</font>. <a href='https://seekingalpha.com/symbol/ADOM' title='ADOMANI, Inc.'>ADOM</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3360380\" data-linked=\"Consumer - Top 5 Gainers / Losers as of 12:00 PM (05/30/2018)\" data-tweet=\"$MOV $MOV $KOSS - Consumer - Top 5 Gainers / Losers as of 12:00 PM (05/30/2018) https://seekingalpha.com/news/3360380-consumer-top-5-gainers-losers-of-12-00-pm-05-30-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3360380-consumer-top-5-gainers-losers-of-12-00-pm-05-30-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360376\" data-ts=\"1527695790\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CEL\" target=\"_blank\">CEL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360376-cellcom-israel-down-4-post-q1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cellcom Israel down 4% post Q1 results</a></h4><ul><li>Cellcom Israel (<a href='https://seekingalpha.com/symbol/CEL' title='Cellcom Israel, Ltd.'>CEL</a> <font color='red'>-4.1%</font>)&nbsp;<u><a href=\"https://seekingalpha.com/filing/4045015\" target=\"_blank\">reports Q1</a></u> revenue decrease of 2.7% Y/Y      to NIS 933M of which Cellular was NIS 630M (-9% Y/Y) &amp; Fixed-line of NIS 343M      (+8.5% Y/Y).</li><li>Cellular&nbsp;segment:      Service revenues      NIS 437M (-14.1% Y/Y); Equipment revenues NIS 193M (+5.5% Y/Y).</li><li>Fixed-line      segment: Service      revenues NIS 304M (+9% Y/Y); Equipment revenues NIS 39M (+5.4% Y/Y).</li><li>Q1      overall margins: Gross&nbsp;<font color='green'>increased 356 bps</font>&nbsp;to 31.5%; operating&nbsp;<font color='red'>declined 217 bps</font>&nbsp;to 4.8% &amp; total EBIDTA&nbsp;<font color='red'>declined 170 bps</font>&nbsp;to 2.3% also, Cellular      EBIDTA&nbsp;<font color='red'>declined 520 bps</font>&nbsp;to 17.8% &amp; Fixed-line EBIDTA&nbsp;<font color='green'>increased 650 bps</font>&nbsp;to 19.8%.</li><li>Performance      Indicators - Cellular:      Cellular subscribers of 2,822 (+1.1% Y/Y); Churn Rate of 9.5% &amp; Monthly cellular average revenue per user of NIS 51.8 (-14% Y/Y).</li><li>Performance      Indicators - Fixed-line: Internet      infrastructure field subscribers&nbsp;of 235 (+35.8% Y/Y) &amp; TV field subscribers of 184 (+48.4% Y/Y).</li><li>\"Cellcom Israel is the only Company in Israel      that offers the quatro package. This advantage allows us to face the      competition in the cellular segment, such that even as cellular prices      decrease, we are successful in selling a complete communications package, and through      this we&nbsp;increase total income per household.\" said Nir Sztern, CEO.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3360159-cellcom-israel-reports-q1-results\" target=\"_blank\">Cellcom Israel reports Q1 results</a> (May 30)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3360376\" data-linked=\"Cellcom Israel down 4% post Q1 results\" data-tweet=\"$CEL - Cellcom Israel down 4% post Q1 results https://seekingalpha.com/news/3360376-cellcom-israel-down-4-post-q1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3360376-cellcom-israel-down-4-post-q1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:56 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360370\" data-ts=\"1527694942\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDP\" target=\"_blank\">MDP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360370-meredithplus-3_7-citi-sees-favorable-risk-reward\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Meredith +3.7% as Citi sees favorable risk/reward</a></h4><ul>   <li>Meredith (NYSE:<a href='https://seekingalpha.com/symbol/MDP' title='Meredith Corporation'>MDP</a>) is <font color='green'>up 3.7%</font> after an upgrade to Buy at Citi, which now sees favorable risk/reward in the pricing.</li>    <li>Shares have fallen 27% in 2018, a decline driven not only by continuing deterioration in print ads but also by its debt level, analyst Jason Bazinet says. But there's room to cut leverage (especially from asset sales), he says. (h/t Bloomberg)</li>    <li>Total debt stands at $3.14B; the company has $372.2M in cash.</li>    <li>Bazinet has bumped his price target to $59 from $58, implying 19% further upside.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3360370\" data-linked=\"Meredith +3.7% as Citi sees favorable risk/reward\" data-tweet=\"$MDP - Meredith +3.7% as Citi sees favorable risk/reward https://seekingalpha.com/news/3360370-meredithplus-3_7-citi-sees-favorable-risk-reward?source=tweet\" data-url=\"https://seekingalpha.com/news/3360370-meredithplus-3_7-citi-sees-favorable-risk-reward\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:42 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360369\" data-ts=\"1527694847\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PCYG\" target=\"_blank\">PCYG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360369-park-city-group-supplier-tech-adopted-food-company\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Park City Group supplier tech adopted by food company</a></h4><ul><li>        Park City Group (NYSEMKT:<a href='https://seekingalpha.com/symbol/PCYG' title='Park City Group, Inc.'>PCYG</a>) subsidiary ReposiTrak <a href=\"https://www.businesswire.com/news/home/20180530005261/en/Neil-Jones-Food-Company-Chooses-ReposiTrak%C2%AE-Eliminate\" target=\"_blank\">announces</a> that the Neil Jones Food Company has adopted its Compliance Management Solution for automating supplier documentation.</li><li>               Neil Jones Food Company is a food manufacturer specializing in tomato and fruit products and is based in Washington state.&nbsp;</li><li>               Park City Group shares are&nbsp;<font color='green'>up 10.1%</font>&nbsp;to $8.15.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3360369\" data-linked=\"Park City Group supplier tech adopted by food company\" data-tweet=\"$PCYG - Park City Group supplier tech adopted by food company https://seekingalpha.com/news/3360369-park-city-group-supplier-tech-adopted-food-company?source=tweet\" data-url=\"https://seekingalpha.com/news/3360369-park-city-group-supplier-tech-adopted-food-company\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:40 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360368\" data-ts=\"1527694787\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MBIO\" target=\"_blank\">MBIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360368-mustang-bios-optimized-car-t-therapy-shows-encouraging-action-in-preclinical-testing-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mustang Bio&#39;s optimized CAR-T therapy shows encouraging action in preclinical testing; shares ahead 3%</a></h4><ul><li>Thinly traded micro cap Mustang Bio (<a href='https://seekingalpha.com/symbol/MBIO' title='Mustang Bio, Inc.'>MBIO</a> <font color='green'>+3.3%</font>) is up on light volume on the heels of its <a href=\"https://seekingalpha.com/pr/17176851-mustang-bio-announces-preclinical-data-potency-car-t-cells-glioblastoma-published-jci-insight\" target=\"_blank\">announcement </a>of positive preclinical results for its optimized CAR-T therapy in glioblastoma. The data were just published in the journal <em>JCI Insight</em>.</li><li>The study, conducted at the City of Hope National Medical Center, showed a greater antitumor effect for Mustang's CD4+ CAR T cells compared to CD8+ CAR T cells.</li><li>A Phase 1 trial in glioblastoma, the most aggressive type of brain tumor, is ongoing. The company plans to incorporate an optimized CAR-T therapy into the study aimed at improving efficacy.</li></ul><div class=\"tiny-share-widget\" data-id=\"3360368\" data-linked=\"Mustang Bio&#39;s optimized CAR-T therapy shows encouraging action in preclinical testing; shares ahead 3%\" data-tweet=\"$MBIO - Mustang Bio&#39;s optimized CAR-T therapy shows encouraging action in preclinical testing; shares ahead 3% https://seekingalpha.com/news/3360368-mustang-bios-optimized-car-t-therapy-shows-encouraging-action-in-preclinical-testing-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3360368-mustang-bios-optimized-car-t-therapy-shows-encouraging-action-in-preclinical-testing-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:39 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360364\" data-ts=\"1527694305\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NANO\" target=\"_blank\">NANO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360364-nanometrics-insider-sells-shares-nanoplus-3_9\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nanometrics insider sells shares; NANO +3.9%</a></h4><ul><li>        Nanometrics (NASDAQ:<a href='https://seekingalpha.com/symbol/NANO' title='Nanometrics Incorporated'>NANO</a>) SVP of Sales and Marketing Rollin Kocher <a href=\"https://seekingalpha.com/filing/4043651\" target=\"_blank\">disposed</a> of 1,496 shares at an average price of $38.67.</li><li>               Kocher also <a href=\"https://seekingalpha.com/filing/4044925\" target=\"_blank\">disposed</a> of 823 shares at an average price of $39.71.</li><li>               Nanometrics shares are&nbsp;<font color='green'>up 3.9%</font>&nbsp;to $41.24.&nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3360364\" data-linked=\"Nanometrics insider sells shares; NANO +3.9%\" data-tweet=\"$NANO $ONTO - Nanometrics insider sells shares; NANO +3.9% https://seekingalpha.com/news/3360364-nanometrics-insider-sells-shares-nanoplus-3_9?source=tweet\" data-url=\"https://seekingalpha.com/news/3360364-nanometrics-insider-sells-shares-nanoplus-3_9\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:31 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360361\" data-ts=\"1527693772\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360361-oil-shoots-higher-on-report-opec-will-maintain-production-curbs\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oil shoots higher on report that OPEC will maintain production curbs</a></h4><ul>     <li>Crude oil prices surge following a Reuters report that Saudi Arabia and the other OPEC and non-OPEC producers would <a href=\"https://www.reuters.com/article/us-oil-opec-saudi/opec-non-opec-sticking-to-oil-pact-but-may-raise-output-if-needed-gulf-source-idUSKCN1IV1XV\" target=\"_blank\">stick with the current production agreement</a> until the end of the year; WTI&nbsp;<font color='green'>+2.1%</font> at $68.18/bbl, Brent <font color='green'>+2.4%</font> at $77.20/bbl.</li>     <li>The oil market is moving towards balance and fundamentals are better than last year, &ldquo;but the group is not ready yet to fully lift controls,&rdquo; Reuters reports, citing a \"Gulf source\" that also says any rise in output when needed would be &ldquo;in a gradual and deliberate fashion.&rdquo;</li>     <li>Prices have been pressured in recent days by expectations that OPEC would lift output to help offset output losses from Iran and Venezuela.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>, <a href='https://seekingalpha.com/symbol/XLE' title='Energy Select Sector SPDR ETF'>XLE</a>, <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P Crude Oil Total Return Index ETN'>OIL</a>, <a href='https://seekingalpha.com/symbol/UWT' title='VelocityShares 3X Long Crude ETN'>UWT</a>, <a href='https://seekingalpha.com/symbol/UCO' title='ProShares Ultra Bloomberg Crude Oil ETF'>UCO</a>, <a href='https://seekingalpha.com/symbol/VDE' title='Vanguard Energy ETF'>VDE</a>, <a href='https://seekingalpha.com/symbol/XOP' title='SPDR S&P Oil & Gas Exploration & Production ETF'>XOP</a>, <a href='https://seekingalpha.com/symbol/DWT' title='VelocityShares 3x Inverse Crude Oil ETN'>DWT</a>, <a href='https://seekingalpha.com/symbol/ERX' title='Direxion Daily Energy Bull 3x Shares ETF'>ERX</a>, <a href='https://seekingalpha.com/symbol/OIH' title='VanEck Vectors Oil Services ETF'>OIH</a>, <a href='https://seekingalpha.com/symbol/SCO' title='ProShares UltraShort Bloomberg Crude Oil ETF'>SCO</a>, <a href='https://seekingalpha.com/symbol/BNO' title='The United States Brent Oil ETF, LP'>BNO</a>, <a href='https://seekingalpha.com/symbol/DBO' title='PowerShares DB Oil ETF'>DBO</a>, <a href='https://seekingalpha.com/symbol/ERY' title='Direxion Daily Energy Bear 3x Shares ETF'>ERY</a>, <a href='https://seekingalpha.com/symbol/DIG' title='ProShares Ultra Oil & Gas ETF'>DIG</a>, <a href='https://seekingalpha.com/symbol/BGR' title='BlackRock Energy&Resources Trust'>BGR</a>, <a href='https://seekingalpha.com/symbol/GUSH' title='Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 3x Shares ETF'>GUSH</a>, <a href='https://seekingalpha.com/symbol/DTO' title='DB Crude Oil Double Short ETN'>DTO</a>, <a href='https://seekingalpha.com/symbol/FENY' title='Fidelity MSCI Energy Index ETF'>FENY</a>, <a href='https://seekingalpha.com/symbol/USL' title='The United States 12 Month Oil ETF, LP'>USL</a>, <a href='https://seekingalpha.com/symbol/IYE' title='iShares U.S. Energy ETF'>IYE</a>, <a href='https://seekingalpha.com/symbol/DUG' title='ProShares UltraShort Oil & Gas ETF'>DUG</a>, <a href='https://seekingalpha.com/symbol/DRIP' title='Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 3x Shares ETF'>DRIP</a>, <a href='https://seekingalpha.com/symbol/IEO' title='iShares U.S. Oil & Gas Exploration & Production ETF'>IEO</a>, <a href='https://seekingalpha.com/symbol/FIF' title='First Trust Energy Infrastructure Fund'>FIF</a>, <a href='https://seekingalpha.com/symbol/DNO' title='The United States Short Oil ETF, LP'>DNO</a>, <a href='https://seekingalpha.com/symbol/NDP' title='Tortoise Energy Independence Fund'>NDP</a>, <a href='https://seekingalpha.com/symbol/PXE' title='PowerShares Dynamic Energy Exploration & Production Portfolio ETF'>PXE</a>, <a href='https://seekingalpha.com/symbol/OLO' title='DB Crude Oil Long ETN'>OLO</a>, <a href='https://seekingalpha.com/symbol/RYE' title='Guggenheim S&P Equal Weight Energy ETF'>RYE</a>, <a href='https://seekingalpha.com/symbol/PXJ' title='PowerShares Dynamic Oil & Gas Services Portfolio ETF'>PXJ</a>, <a href='https://seekingalpha.com/symbol/SZO' title='DB Crude Oil Short ETN'>SZO</a>, <a href='https://seekingalpha.com/symbol/CRAK' title='VanEck Vectors Oil Refiners ETF'>CRAK</a>, <a href='https://seekingalpha.com/symbol/FXN' title='First Trust Energy AlphaDEX ETF'>FXN</a>, <a href='https://seekingalpha.com/symbol/OLEM' title='iPath Pure Beta Crude Oil ETN'>OLEM</a>, <a href='https://seekingalpha.com/symbol/WTIU' title='ProShares Daily 3x Long Crude ETN'>WTIU</a>, <a href='https://seekingalpha.com/symbol/DDG' title='ProShares Short Oil & Gas ETF'>DDG</a>, <a href='https://seekingalpha.com/symbol/OILK' title='ProShares K-1 Free Crude Oil Strategy ETF'>OILK</a>, <a href='https://seekingalpha.com/symbol/NANR' title='SPDR S&P North American Natural Resources ETF'>NANR</a>, <a href='https://seekingalpha.com/symbol/OILX' title='Etracs S&P GSCI Crude Oil Total Return Index ETN'>OILX</a>, <a href='https://seekingalpha.com/symbol/WTID' title='ProShares Daily 3x Inverse Crude ETN'>WTID</a>, <a href='https://seekingalpha.com/symbol/USOI' title='Credit Suisse Crude Oil Shares Covered Call ETN'>USOI</a>, <a href='https://seekingalpha.com/symbol/USOU' title='United States 3x Oil Fund'>USOU</a>, <a href='https://seekingalpha.com/symbol/USOD' title='United States 3x Short Oil Fund ETF'>USOD</a>, <a href='https://seekingalpha.com/symbol/FTXN' title='First Trust Nasdaq Oil & Gas ETF'>FTXN</a>, <a href='https://seekingalpha.com/symbol/JHME' title='John Hancock Multifactor Energy ETF'>JHME</a>, <a href='https://seekingalpha.com/symbol/UBRT' title='Credit Suisse AxelaTrader 3x Long Brent Crude Oil ETN'>UBRT</a>, <a href='https://seekingalpha.com/symbol/ERYY' title='Direxion Daily Energy Bear 1x Shares ETF'>ERYY</a>, <a href='https://seekingalpha.com/symbol/DBRT' title='Credit Suisse AxelaTrader 3x Inverse Brent Crude Oil ETN'>DBRT</a>, <a href='https://seekingalpha.com/symbol/ERGF' title='iShares Edge MSCI Multifactor Energy ETF'>ERGF</a>, <a href='https://seekingalpha.com/symbol/OILD' title='ProShares UltraPro 3x Short Crude Oil ETF'>OILD</a>, <a href='https://seekingalpha.com/symbol/OILU' title='ProShares UltraPro 3x Crude Oil ETF'>OILU</a>, <a href='https://seekingalpha.com/symbol/USAI' title='American Energy Independence ETF'>USAI</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3360361\" data-linked=\"Oil shoots higher on report that OPEC will maintain production curbs\" data-tweet=\"$USO $XLE $OIL - Oil shoots higher on report that OPEC will maintain production curbs https://seekingalpha.com/news/3360361-oil-shoots-higher-on-report-opec-will-maintain-production-curbs?source=tweet\" data-url=\"https://seekingalpha.com/news/3360361-oil-shoots-higher-on-report-opec-will-maintain-production-curbs\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>80&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360358\" data-ts=\"1527693646\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARAY\" target=\"_blank\">ARAY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360358-studies-show-value-proposition-of-accurays-tomotherapy-shares-up-8\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Studies show value proposition of AccuRay&#39;s TomoTherapy; shares up 8%</a></h4><ul><li>Accuray (<a href='https://seekingalpha.com/symbol/ARAY' title='Accuray Incorporated'>ARAY</a> <font color='green'>+8.1%</font>) is up on below-average volume on the heels of its <a href=\"https://seekingalpha.com/pr/17176858-new-studies-show-accuray-tomotherapy-system-provides-greater-precision-excellent-clinical\" target=\"_blank\">announcement </a>of results from two studies demonstrating the benefits of TomoTherapy in total body irradiation &#40;TBI&#41;, a procedure used to prepare leukemia and multiple myeloma patients for bone marrow transplant.</li><li>The first study, conducted in Toulouse, France, showed TBI delivered via the TomoTherapy platform facilitated the successful engraftment of 100% of patients (n=11) while avoiding radiation pneumonitis, inflammation of the lung that commonly occurs in patients undergoing radiation therapy.</li><li>The second study, conducted in Guangzhou, China, TomoTherapy was used to deliver TBI and a targeted dose of radiation to non-bone sites to improve outcomes in treatment-resistant leukemia patients. All patients achieved sustained full donor stem cell engraftment. At one year post procedure, the survival rate and disease-free survival rate were both 70.7%. No patient relapsed after a median follow-up period of 14.6 months.</li></ul><div class=\"tiny-share-widget\" data-id=\"3360358\" data-linked=\"Studies show value proposition of AccuRay&#39;s TomoTherapy; shares up 8%\" data-tweet=\"$ARAY - Studies show value proposition of AccuRay&#39;s TomoTherapy; shares up 8% https://seekingalpha.com/news/3360358-studies-show-value-proposition-of-accurays-tomotherapy-shares-up-8?source=tweet\" data-url=\"https://seekingalpha.com/news/3360358-studies-show-value-proposition-of-accurays-tomotherapy-shares-up-8\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360357\" data-ts=\"1527692923\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANGI\" target=\"_blank\">ANGI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360357-angi-homeservicesplus-1_9-deutsche-bank-starts-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ANGI Homeservices +1.9% as Deutsche Bank starts at Buy</a></h4><ul>   <li>ANGI Homeservices (NASDAQ:<a href='https://seekingalpha.com/symbol/ANGI' title='ANGI Homeservices Inc.'>ANGI</a>) is <font color='green'>up 1.9%</font> after an initiation at Buy by Deutsche Bank.</li>    <li>The firm set its price target at $18, implying 16% further upside.</li>    <li>Shares are <font color='green'>up 45.6%</font> YTD and <font color='green'>up 28.7%</font> over the past 12 months.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3360357\" data-linked=\"ANGI Homeservices +1.9% as Deutsche Bank starts at Buy\" data-tweet=\"$ANGI - ANGI Homeservices +1.9% as Deutsche Bank starts at Buy https://seekingalpha.com/news/3360357-angi-homeservicesplus-1_9-deutsche-bank-starts-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/3360357-angi-homeservicesplus-1_9-deutsche-bank-starts-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:08 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360352\" data-ts=\"1527692485\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OGEN\" target=\"_blank\">OGEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360352-healthcare-top-5-gainers-losers-of-11-00-05-30-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 AM (05/30/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/OGEN' title='Oragenics, Inc.'>OGEN</a> <font color='green'>+60%</font>. TPIV <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/SESN' title='Sesen Bio, Inc.'>SESN</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/IMMP' title='Immutep Limited ADR'>IMMP</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/NSPR' title='InspireMD, Inc.'>NSPR</a> <font color='green'>+13%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/NVUS' title='Novus Therapeutics'>NVUS</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/RIGL' title='Rigel Pharmaceuticals, Inc.'>RIGL</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/FWP' title='Forward Pharma'>FWP</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/AVGR' title='Avinger'>AVGR</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/GENE' title='GENETIC TECHNOLOGIES LTD'>GENE</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3360352\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 AM (05/30/2018)\" data-tweet=\"$OGEN $OGEN $MRKR - Healthcare - Top 5 Gainers / Losers as of 11:00 AM (05/30/2018) https://seekingalpha.com/news/3360352-healthcare-top-5-gainers-losers-of-11-00-05-30-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3360352-healthcare-top-5-gainers-losers-of-11-00-05-30-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360350\" data-ts=\"1527692293\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ASYS\" target=\"_blank\">ASYS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360350-amtech-systemsplus-13_1-no-clear-catalyst\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amtech Systems +13.1% with no clear catalyst</a></h4><ul><li>           Amtech Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/ASYS' title='Amtech Systems, Inc.'>ASYS</a>) shares are&nbsp;<font color='green'>up 13.1%</font>&nbsp;to $10.36 with no clear catalyst. </li><li> Amtech shares are&nbsp;<font color='green'>up 3.5%</font>&nbsp;for the past week,&nbsp;<font color='green'>33.1%</font>&nbsp;in the past month, and&nbsp;<font color='red'>down 9%</font>&nbsp;YTD.&nbsp; </li></ul><div class=\"tiny-share-widget\" data-id=\"3360350\" data-linked=\"Amtech Systems +13.1% with no clear catalyst\" data-tweet=\"$ASYS - Amtech Systems +13.1% with no clear catalyst https://seekingalpha.com/news/3360350-amtech-systemsplus-13_1-no-clear-catalyst?source=tweet\" data-url=\"https://seekingalpha.com/news/3360350-amtech-systemsplus-13_1-no-clear-catalyst\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360323\" data-ts=\"1527692127\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HEI\" target=\"_blank\">HEI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360323-heico-drops-5-despite-q2-beat-higher-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">HEICO drops 5% despite Q2 beat, higher outlook</a></h4><ul><li>HEICO (<a href='https://seekingalpha.com/symbol/HEI' title='HEICO Corporation'>HEI</a> <font color='red'>-5.2%</font>) reported Q2 net sales growth of 16.8% Y/Y to $430.6M. Segment sales: The flight support group increased 16% Y/Y to $267.8M attributed to the acquisitions and organic growth, and electronic technologies group increased 20% Y/Y to $168.7M due to acquisitions.</li><li>Q2 Overall operating margin&nbsp;<font color='green'>improved by 50 bps</font>&nbsp;to 21.3%. Segment operating margins: the flight support group&nbsp;<font color='red'>declined by 10 bps</font>&nbsp;to 19.2% and electronic technologies group i<font color='green'>mproved by 102 bps</font>&nbsp;to 28.5%.</li><li>SG&amp;A expenses were up 16.3% Y/Y to $76.3M.</li><li>Company&rsquo;s tax rate for first 6 months of FY18 was 14.8% down from 29.5% in FY17.</li><li>FY18 Outlook: Net sales growth of 13-14% from 12-14% and net income 33-35% from 30-32%; operating margin ~21% from 20-21%; cash flow from operations ~$310M; capex ~$50M and depreciation &amp; amortization expenses of ~$77M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3360102-heico-beats-0_02-beats-revenue\" target=\"_blank\">HEICO beats by $0.02, beats on revenue</a> (May 29)</li></ul><div class=\"tiny-share-widget\" data-id=\"3360323\" data-linked=\"HEICO drops 5% despite Q2 beat, higher outlook\" data-tweet=\"$HEI - HEICO drops 5% despite Q2 beat, higher outlook https://seekingalpha.com/news/3360323-heico-drops-5-despite-q2-beat-higher-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3360323-heico-drops-5-despite-q2-beat-higher-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:55 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360347\" data-ts=\"1527691855\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LGCY\" target=\"_blank\">LGCY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360347-legacy-reservesplus-16-major-shareholder-keeps-buying\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Legacy Reserves +16% as major shareholder keeps buying</a></h4><ul>     <li>Legacy Reserves (<a href='https://seekingalpha.com/symbol/LGCY' title='Legacy Reserves Inc'>LGCY</a> <font color='green'>+15.9%</font>) shoots higher after 10% shareholder Baines Creek <a href=\"https://www.sec.gov/Archives/edgar/data/1358831/000167660118000036/xslF345X03/primary_doc.xml\" target=\"_blank\">discloses</a> the purchase of 80K shares at $5.56/share worth ~$445K.</li>     <li>Baines has been <a href=\"https://transcriptdaily.com/2018/05/30/legacy-reserves-lp-lgcy-major-shareholder-baines-creek-capital-llc-purchases-80000-shares-of-stock.html\" target=\"_blank\">actively buying up</a> LGCY shares in recent weeks, purchasing more than 550K shares since March 23.</li>     <li>UBS <a href=\"https://marketrealist.com/2018/05/mlp-rating-updates-for-the-week-ending-may-18\" target=\"_blank\">recently upgraded</a> LGCY to Neutral from Sell with an $8 price target.</li></ul><div class=\"tiny-share-widget\" data-id=\"3360347\" data-linked=\"Legacy Reserves +16% as major shareholder keeps buying\" data-tweet=\"$LGCY - Legacy Reserves +16% as major shareholder keeps buying https://seekingalpha.com/news/3360347-legacy-reservesplus-16-major-shareholder-keeps-buying?source=tweet\" data-url=\"https://seekingalpha.com/news/3360347-legacy-reservesplus-16-major-shareholder-keeps-buying\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360346\" data-ts=\"1527691753\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SGLB\" target=\"_blank\">SGLB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360346-sigma-labsplus-91_5-on-new-quality-control-tech\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sigma Labs +91.5% on new quality control tech</a></h4><ul><li>        Sigma Labs (NASDAQ:<a href='https://seekingalpha.com/symbol/SGLB' title='Sigma Labs, Inc.'>SGLB</a>) <a href=\"https://globenewswire.com/news-release/2018/05/30/1513830/0/en/Sigma-Labs-Demonstrates-Proof-of-Concept-for-Closed-Loop-Quality-Control-During-Metal-Additive-Manufacturing.html\" target=\"_blank\">announces</a> the development of closed-loop feedback control of the metal laser power bed fusion 3D printing process.</li><li>               The system uses the PrintRite 3D tech to monitor process output and extracting process metrics, compares those to baseline metrics, and determines parameter value changes.&nbsp;</li><li>               Sigma has demonstrated the new system and plans beta testing with select end-user customers.&nbsp;</li><li>               Sigma Labs shares are&nbsp;<font color='green'>up 91.5%&nbsp;</font>to $2.53.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3360346\" data-linked=\"Sigma Labs +91.5% on new quality control tech\" data-tweet=\"$SGLB - Sigma Labs +91.5% on new quality control tech https://seekingalpha.com/news/3360346-sigma-labsplus-91_5-on-new-quality-control-tech?source=tweet\" data-url=\"https://seekingalpha.com/news/3360346-sigma-labsplus-91_5-on-new-quality-control-tech\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:49 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360342\" data-ts=\"1527691235\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EXAS\" target=\"_blank\">EXAS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360342-exact-sciences-up-8-on-new-acs-screening-guidelines-for-crc\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Exact Sciences up 8% on new ACS screening guidelines for CRC</a></h4><ul><li>Exact Sciences (<a href='https://seekingalpha.com/symbol/EXAS' title='EXACT Sciences Corporation'>EXAS</a> <font color='green'>+7.6%</font>) is up on below-average volume in apparent response to <a href=\"https://www.cancer.org/latest-news/american-cancer-society-updates-colorectal-cancer-screening-guideline.html\" target=\"_blank\">new guidelines</a> from the American Cancer Society &#40;ACS&#41;&nbsp;recommending colorectal cancer &#40;CRC&#41; screening at age 45 (previously 50) in average-risk adults.</li><li>The ACS updated its guidelines in response to higher CRC rates in younger adults. Individuals at higher risk include African Americans, Alaska Natives and people with a family history or personal history of colon or rectal polyps.</li><li>The company generates all of its revenue from its Cologuard colon cancer screening test service.</li></ul><div class=\"tiny-share-widget\" data-id=\"3360342\" data-linked=\"Exact Sciences up 8% on new ACS screening guidelines for CRC\" data-tweet=\"$EXAS - Exact Sciences up 8% on new ACS screening guidelines for CRC https://seekingalpha.com/news/3360342-exact-sciences-up-8-on-new-acs-screening-guidelines-for-crc?source=tweet\" data-url=\"https://seekingalpha.com/news/3360342-exact-sciences-up-8-on-new-acs-screening-guidelines-for-crc\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360340\" data-ts=\"1527690992\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOGO\" target=\"_blank\">GOGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360340-gogo-slides-8_8-morgan-stanley-frets-funding\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gogo slides 8.8% as Morgan Stanley frets funding</a></h4><ul>   <li>Gogo (NASDAQ:<a href='https://seekingalpha.com/symbol/GOGO' title='Gogo'>GOGO</a>) has <font color='red'>tumbled 8.8%</font> after a worrisome note from Morgan Stanley, which has slashed its price target amid a \"difficult situation\" with funding.</li>    <li>The company's recent results are surfacing questions about the company's financial model (amid a shift from B2C to B2B) and ability to generate free cash flow, says analyst Simon Flannery, who's not convinced a new CEO can address all the issues in a \"timely manner.\" (h/t Bloomberg)</li>    <li>The company's facing increased competition in business aviation from the likes of ViaSat (VSAT <font color='green'>+2.1%</font>) and SmartSky, and it could be years before meaningful revenue growth in domestic commercial aviation.</li>    <li>He's cut the firm's price target to $3, from $7, implying 37% further downside from today's lower price.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3360340\" data-linked=\"Gogo slides 8.8% as Morgan Stanley frets funding\" data-tweet=\"$GOGO - Gogo slides 8.8% as Morgan Stanley frets funding https://seekingalpha.com/news/3360340-gogo-slides-8_8-morgan-stanley-frets-funding?source=tweet\" data-url=\"https://seekingalpha.com/news/3360340-gogo-slides-8_8-morgan-stanley-frets-funding\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>44&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360338\" data-ts=\"1527690933\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CVCO\" target=\"_blank\">CVCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360338-cavco-industries-up-8-on-estimate-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cavco Industries up 8% on estimate beat</a></h4><ul><li>Cavco Industries (<a href='https://seekingalpha.com/symbol/CVCO' title='Cavco Industries, Inc.'>CVCO</a> <font color='green'>+8.1%</font>)&nbsp;<u><a href=\"https://seekingalpha.com/filing/4044436\" target=\"_blank\">reports Q4</a></u>&nbsp;revenue growth of 22.5% Y/Y      to $242.5M of which Factory-built housing was $228.1M (+23.6% Y/Y) &amp; Financial      services of $14.5M (+7.4% Y/Y), the increase was the result of higher home prices &amp;      sales volume.</li><li>Q4 overall margins: Gross<font color='green'> increased 113 bps</font>&nbsp;to 22.39%; Operating&nbsp;<font color='green'>increased 209&nbsp;</font>bps to 10.7% &amp; Net margin&nbsp;<font color='green'>increased 319 bps</font>&nbsp;to 8.7%.</li><li>Total      factory-built homes sold were 4,063 (+9.9% YY).</li><li>Cash      &amp; equivalents of $186.8M (+41% Y/Y) &amp; Capex was 5.4M (+463.1%      Y/Y).</li><li>&ldquo;2019      begins with optimism about demand for housing as home ownership rates,      currently at a low 64.2%, are reported to be trending higher. With housing      prices and rental rates also on the rise, we believe systems-built housing      will be an increasingly sought after option for affordable living.\"      said Joseph Stegmayer, Chairman, President &amp; CEO.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3360093-cavco-beats-0_88-beats-revenue\" target=\"_blank\">Cavco beats by $0.88, beats on revenue</a> (May 29)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3360338\" data-linked=\"Cavco Industries up 8% on estimate beat\" data-tweet=\"$CVCO - Cavco Industries up 8% on estimate beat https://seekingalpha.com/news/3360338-cavco-industries-up-8-on-estimate-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3360338-cavco-industries-up-8-on-estimate-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:35 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360334\" data-ts=\"1527690372\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CPRI\" target=\"_blank\">CPRI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360334-michael-kors-backtracks-after-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Michael Kors backtracks after earnings</a></h4><ul> <li>Investors have turned skittish on Michael Kors (KORS <font color='red'>-10.4%</font>) after the company's full-year profit guidance suggests some stumbles could be ahead.</li><li>Technical traders also making quite a bit of noise about some warning signs with their tracking of the charts.</li> <li>Either way, shares of KORS are now at their lowest level since February on the turnaround in sentiment.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3360203-michael-kors-tops-comparable-sales-estimates\" target=\"_blank\">Michael Kors tops comparable sales estimates</a> (May 30)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3360334\" data-linked=\"Michael Kors backtracks after earnings\" data-tweet=\"$CPRI - Michael Kors backtracks after earnings https://seekingalpha.com/news/3360334-michael-kors-backtracks-after-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3360334-michael-kors-backtracks-after-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360331\" data-ts=\"1527690152\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MOMO\" target=\"_blank\">MOMO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360331-benchmark-raises-momo-target-after-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Benchmark raises Momo target after earnings</a></h4><ul><li>        Benchmark raises its Momo (NASDAQ:<a href='https://seekingalpha.com/symbol/MOMO' title='Momo'>MOMO</a>) price target from $48 to $60 after yesterday&rsquo;s earnings report.</li><li>               Firm says Momo&rsquo;s VAS business continues to show strong growth and Benchmark sees initial progress of Tantan monetization, which should contribute more to VAS in 2H.&nbsp;</li><li>                  Source: Briefing.com.    </li><li>               Momo shares are&nbsp;<font color='red'>down 2.6%</font>&nbsp;to $43.68 erasing some of yesterday&rsquo;s gains. Momo shares are&nbsp;<font color='green'>up 12.5%</font>&nbsp;for the week and&nbsp;<font color='green'>83.3%</font>&nbsp;YTD.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3359863-momo-plus-9_2-percent-q1-beats-18-percent-mau-growth\" target=\"_blank\">Momo +9.2% on Q1 beats, 18% MAU growth</a> (May 29)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3360080-momo-plus-14_7-percent-analysts-chime-earnings-topper\" target=\"_blank\">Momo +14.7% as analysts chime in after earnings topper</a> (May 29)</li></ul><div class=\"tiny-share-widget\" data-id=\"3360331\" data-linked=\"Benchmark raises Momo target after earnings\" data-tweet=\"$MOMO - Benchmark raises Momo target after earnings https://seekingalpha.com/news/3360331-benchmark-raises-momo-target-after-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3360331-benchmark-raises-momo-target-after-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360328\" data-ts=\"1527689683\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FCAU\" target=\"_blank\">FCAU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360328-major-strategy-reset-on-tap-fiat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Major strategy reset on tap at Fiat</a></h4><ul> <li>The master plan of Fiat Chrysler Automobile (<a href='https://seekingalpha.com/symbol/FCAU' title='Fiat Chrysler Automobiles NV'>FCAU</a> <font color='green'>+5.4%</font>) CEO Sergio Marchionne is to <a href=\"https://www.bloomberg.com/news/articles/2018-05-30/marchionne-s-grand-finale-entails-expanding-jeep-shrinking-fiat\" target=\"_blank\">steer</a> towards Jeep SUVs and Maserati models, while ending the sale of the Fiat brands in the U.S. and China, reports Bloomberg's Tommaso Ebhardt.</li> <li>Sources say Chrysler may be limited to sales in the U.S. as part of the strategy reset, while Jeep - which accounts for 70% of all the company's profits - will see its sales target double from the current volume.</li><li>The new direction is a significant departure from Marchionne's previous calls for M&amp;A within the sector.</li> <li>Marchionne is due to release the strategy update during a media briefing on Friday.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3360306-fiat-chrysler-pops-brand-exit-report\" target=\"_blank\">Fiat Chrysler pops on brand exit report</a> (May 30)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3360328\" data-linked=\"Major strategy reset on tap at Fiat\" data-tweet=\"$FCAU - Major strategy reset on tap at Fiat https://seekingalpha.com/news/3360328-major-strategy-reset-on-tap-fiat?source=tweet\" data-url=\"https://seekingalpha.com/news/3360328-major-strategy-reset-on-tap-fiat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360326\" data-ts=\"1527689652\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XOM\" target=\"_blank\">XOM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360326-exxonplus-2-rbc-upgrades-foreseeing-substantial-dividend-growth\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Exxon +2% as RBC upgrades, foreseeing substantial dividend growth</a></h4><ul>     <li>Exxon Mobil (<a href='https://seekingalpha.com/symbol/XOM' title='Exxon Mobil Corporation'>XOM</a> <font color='green'>+2.3%</font>) surges in early trading after RBC Capital <a href=\"https://www.cnbc.com/2018/05/30/buy-exxon-mobil-because-of-its-substantial-dividend-growth-rbc.html\" target=\"_blank\">upgrades</a> shares to Outperform from Sector Perform with a $100 price target, up from $90, citing strong capital returns including share buybacks and dividends.</li><li>\"A combination of disappointing results and the acceleration of its  investment plans has led Exxon to underperform peers significantly  recently,\" RBC analyst Biraj Borkhataria writes. \"From now to 2025, we see the potential for substantial  dividend growth alongside superior returns, both of which appear  underappreciated to us.\"</li><li>The firm also says XOM \"has historically been one of the most successful super-majors at  investing through the business cycle and taking advantage of downturns  by lowering its cost structure and high-grading its asset base.\"</li><li>Borkhataria predicts XOM will raise its dividend by 4% in  2019 and then 5%/year starting in 2020, and expects XOM's share buybacks to rise materially after 2020.</li></ul><div class=\"tiny-share-widget\" data-id=\"3360326\" data-linked=\"Exxon +2% as RBC upgrades, foreseeing substantial dividend growth\" data-tweet=\"$XOM - Exxon +2% as RBC upgrades, foreseeing substantial dividend growth https://seekingalpha.com/news/3360326-exxonplus-2-rbc-upgrades-foreseeing-substantial-dividend-growth?source=tweet\" data-url=\"https://seekingalpha.com/news/3360326-exxonplus-2-rbc-upgrades-foreseeing-substantial-dividend-growth\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>32&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360321\" data-ts=\"1527688993\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DRNA\" target=\"_blank\">DRNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360321-dicerna-advancing-ph-candidate-in-early-stage-study-shares-up-4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dicerna advancing PH candidate in early-stage study; shares up 4%</a></h4><ul><li>The first primary hyperoxaluria &#40;PH&#41; patient has been <a href=\"https://seekingalpha.com/pr/17176845-dicerna-doses-first-primary-hyperoxaluria-patient-dcr-phxc-group-b-portion-phyox-phase-1\" target=\"_blank\">dosed </a>in Dicerna Pharmaceuticals' (<a href='https://seekingalpha.com/symbol/DRNA' title='Dicerna Pharmaceuticals, Inc.'>DRNA</a> <font color='green'>+3.5%</font>) Phase 1 clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT03392896?intr=dcr-phxc&amp;spons=dicerna&amp;rank=1\" target=\"_blank\">PHYOX</a>, evaluating Orphan Drug-tagged DCR-PHXC, its lead RNAi therapeutic based on its GalXC platform that enables subcutaneous administration.</li><li>Proof-of-concept data should be available in H2.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3317019-early-stage-study-underway-assessing-dicernas-lead-candidate-rare-liver-disorder\" target=\"_blank\">Early-stage study underway assessing Dicerna's lead candidate in rare liver disorder</a> (Dec. 7, 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3360321\" data-linked=\"Dicerna advancing PH candidate in early-stage study; shares up 4%\" data-tweet=\"$DRNA - Dicerna advancing PH candidate in early-stage study; shares up 4% https://seekingalpha.com/news/3360321-dicerna-advancing-ph-candidate-in-early-stage-study-shares-up-4?source=tweet\" data-url=\"https://seekingalpha.com/news/3360321-dicerna-advancing-ph-candidate-in-early-stage-study-shares-up-4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:03 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360312\" data-ts=\"1527688529\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DKS\" target=\"_blank\">DKS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360312-sporting-goods-sector-reacts-to-dicks-stunner\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sporting goods sector reacts to Dick&#39;s stunner</a></h4><ul> <li>Shares of Dick's Sporting Goods (NYSE:<a href='https://seekingalpha.com/symbol/DKS' title='Dick&#39;s Sporting Goods, Inc.'>DKS</a>) sail to a&nbsp;<font color='green'>21.3% post-earnings gain</font>&nbsp;after weakness in the hunting category is easily offset in Q1 and full-year profit guidance impresses.</li> <li>New products and a tighter lid on promotions led to improved merchandise margins for the retailer.</li> <li>Under Armour (NYSE:<a href='https://seekingalpha.com/symbol/UAA' title='Under Armour, Inc.'>UAA</a>) is <font color='green'>up 3.15%</font>, Johnson Outdoors (NASDAQ:<a href='https://seekingalpha.com/symbol/JOUT' title='Johnson Outdoors Inc.'>JOUT</a>) is <font color='green'>1.71% higher</font>, Hibbett Sports (NASDAQ:<a href='https://seekingalpha.com/symbol/HIBB' title='Hibbett Sports, Inc.'>HIBB</a>) i<font color='green'>s 1.22% higher</font> and Big Five Sporting Goods (NASDAQ:<a href='https://seekingalpha.com/symbol/BGFV' title='Big 5 Sporting Goods Corporation'>BGFV</a>) is showing off a <font color='green'>2.22% rise</font>. Other names like Nike (<a href='https://seekingalpha.com/symbol/NKE' title='Nike Inc.'>NKE</a> <font color='green'>+0.5%</font>), Columbia Sportwear (<a href='https://seekingalpha.com/symbol/COLM' title='Columbia Sportswear Company'>COLM</a> <font color='green'>+0.5%</font>) and V.F. Corp (<a href='https://seekingalpha.com/symbol/VFC' title='V.F. Corporation'>VFC</a> <font color='green'>+0.1%</font>) are showing are more muted reactions, possibly because Dick's pointed to strength with \"private\" brands during the quarter.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3360226-strong-profit-guidance-lifts-dicks-sporting-goods\" target=\"_blank\">Strong profit guidance lifts Dick's Sporting Goods</a> (May 30)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3360312\" data-linked=\"Sporting goods sector reacts to Dick&#39;s stunner\" data-tweet=\"$DKS $DKS $UAA - Sporting goods sector reacts to Dick&#39;s stunner https://seekingalpha.com/news/3360312-sporting-goods-sector-reacts-to-dicks-stunner?source=tweet\" data-url=\"https://seekingalpha.com/news/3360312-sporting-goods-sector-reacts-to-dicks-stunner\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360308\" data-ts=\"1527688082\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AGN\" target=\"_blank\">AGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360308-allergan-to-jettison-womens-health-and-infectious-disease-units-cnbc\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Allergan to jettison women&#39;s health and infectious disease units - CNBC</a></h4><ul><li>CNBC <a href=\"https://www.cnbc.com/2018/05/30/allergan-to-sell-womens-health-and-infectious-disease-units-after-strategic-review-sources.html\" target=\"_blank\">reports </a>that Allergan (<a href='https://seekingalpha.com/symbol/AGN' title='Allergan plc'>AGN</a> <font color='red'>-1.7%</font>) has completed its previously announced strategic review and will divest its women's health and infectious disease businesses. The units could fetch $4B and $2B, respectively, according to Cowen.</li><li><strong>Update</strong>: At the Bernstein conference, the company stated that it will only sell the units at good prices, no fire sales planned, considering their profitability and growth prospects. Net proceeds will be used to pare down debt and for share buybacks.</li></ul><div class=\"tiny-share-widget\" data-id=\"3360308\" data-linked=\"Allergan to jettison women&#39;s health and infectious disease units - CNBC\" data-tweet=\"$AGN - Allergan to jettison women&#39;s health and infectious disease units - CNBC https://seekingalpha.com/news/3360308-allergan-to-jettison-womens-health-and-infectious-disease-units-cnbc?source=tweet\" data-url=\"https://seekingalpha.com/news/3360308-allergan-to-jettison-womens-health-and-infectious-disease-units-cnbc\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360306\" data-ts=\"1527687710\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FCAU\" target=\"_blank\">FCAU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360306-fiat-chrysler-pops-on-brand-exit-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fiat Chrysler pops on brand exit report</a></h4><ul> <li>Fiat Chrysler (NYSE:<a href='https://seekingalpha.com/symbol/FCAU' title='Fiat Chrysler Automobiles NV'>FCAU</a>) is&nbsp;<font color='green'>up 3.92%</font>&nbsp;in early trading after Bloomberg reports that the automaker is considering a brand exit.</li> <li>The story is developing. Details will be added as they are ascertained.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3360306\" data-linked=\"Fiat Chrysler pops on brand exit report\" data-tweet=\"$FCAU - Fiat Chrysler pops on brand exit report https://seekingalpha.com/news/3360306-fiat-chrysler-pops-on-brand-exit-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3360306-fiat-chrysler-pops-on-brand-exit-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360303\" data-ts=\"1527687535\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARWR\" target=\"_blank\">ARWR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360303-arrowhead-completes-enrollment-in-first-stage-of-phase-1-2-study-of-aro-hbv-shares-up-5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Arrowhead completes enrollment in first stage of Phase 1/2 study of ARO-HBV; shares up 5%</a></h4><ul><li>Arrowhead Pharmaceuticals (<a href='https://seekingalpha.com/symbol/ARWR' title='Arrowhead Pharmaceuticals'>ARWR</a> <font color='green'>+4.9%</font>) <a href=\"https://seekingalpha.com/pr/17176844-arrowhead-completes-enrollment-single-dose-portion-phase-1-2-study-aro-hbv\" target=\"_blank\">completes the enrollment</a> of 30 subjects in the single-ascending dose portion of its Phase 1/2 clinical trial assessing RNAi therapeutic ARO-HBV for the treatment of chronic hepatitis B virus &#40;HBV&#41; infection.</li><li>The study is evaluating the safety, tolerability and pharmacokinetics of single-ascending doses of ARO-HBV in healthy adult volunteers and the safety, tolerability and pharmacodynamics of multiple-ascending doses in patients with chronic HBV.</li><li>Preliminary data will be submitted for presentation at <a href=\"https://www.aasld.org/events-professional-development/liver-meeting\" target=\"_blank\">The Liver Meeting</a> in San Francisco, November 9 - 13.</li></ul><div class=\"tiny-share-widget\" data-id=\"3360303\" data-linked=\"Arrowhead completes enrollment in first stage of Phase 1/2 study of ARO-HBV; shares up 5%\" data-tweet=\"$ARWR - Arrowhead completes enrollment in first stage of Phase 1/2 study of ARO-HBV; shares up 5% https://seekingalpha.com/news/3360303-arrowhead-completes-enrollment-in-first-stage-of-phase-1-2-study-of-aro-hbv-shares-up-5?source=tweet\" data-url=\"https://seekingalpha.com/news/3360303-arrowhead-completes-enrollment-in-first-stage-of-phase-1-2-study-of-aro-hbv-shares-up-5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:38 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360300\" data-ts=\"1527687140\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BAYRY\" target=\"_blank\">BAYRY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360300-bayerplus-4-after-winning-u-s-approval-for-monsanto-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bayer +4% after winning U.S. approval for Monsanto deal</a></h4><ul>     <li>Bayer (<a href='https://seekingalpha.com/symbol/BAYRY' title='Bayer A.G. ADR'>OTCPK:BAYRY</a>) <font color='green'>+4.2%</font> to lead Germany's DAX after <a href=\"https://seekingalpha.com/news/3360010-bayer-wins-u-s-approval-monsanto-purchase\" target=\"_blank\">winning U.S. antitrust approval</a> for its planned takeover of Monsanto, at a cost of $9B in required asset sales that are the &ldquo;largest ever divestiture ever required by the United States.&rdquo;</li>     <li>Bayer says the planned sale of businesses with 2.2B ($2.54B) in sales to BASF that were already agreed to address antitrust concerns, mainly in Europe, are <a href=\"https://www.reuters.com/article/us-monsanto-m-a-bayer-doj/bayer-wins-u-s-nod-for-monsanto-deal-to-create-agriculture-giant-idUSKCN1IU1DO\" target=\"_blank\">not materially different</a> from the demands of the U.S. Department of Justice.</li>     <li>Bayer also says the European Commission had approved BASF as a suitable buyer of the businesses to be divested; German seed seller KWS Saat, which had made a late bid for Bayer&rsquo;s vegetable seed business, says it accepts the EC&rsquo;s decision.</li><li>The Bayer-Monsanto merger still requires clearance in Canada and Mexico.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3360300\" data-linked=\"Bayer +4% after winning U.S. approval for Monsanto deal\" data-tweet=\"$BAYRY - Bayer +4% after winning U.S. approval for Monsanto deal https://seekingalpha.com/news/3360300-bayerplus-4-after-winning-u-s-approval-for-monsanto-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3360300-bayerplus-4-after-winning-u-s-approval-for-monsanto-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360292\" data-ts=\"1527686493\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OGEN\" target=\"_blank\">OGEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360292-premarket-gainers-of-9-05-05-30-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am (05/30/2018)</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/OGEN' title='Oragenics, Inc.'>OGEN</a> <font color='green'>+46%</font>&nbsp;on favorable safety profile in mid-stage OM <a href=\"https://seekingalpha.com/news/3360227-oragenics-ag013-shows-favorable-safety-profile-mid-stage-om-study-shares-34-percent-premarket\" target=\"_blank\">study</a>.</li>     <li><a href='https://seekingalpha.com/symbol/CODX' title='Co-Diagnostics'>CODX</a> <font color='green'>+28%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/DKS' title='Dick&#39;s Sporting Goods, Inc.'>DKS</a> <font color='green'>+23%</font>&nbsp;on Q1 <a href=\"https://seekingalpha.com/news/3360217-dicks-sporting-goods-beats-0_14-beats-revenue\" target=\"_blank\">result</a>.</li>     <li><a href='https://seekingalpha.com/symbol/MOV' title='Movado Group, Inc.'>MOV</a> <font color='green'>+14%</font>&nbsp;on Q1 <a href=\"https://seekingalpha.com/news/3360188-movado-beats-0_26-beats-revenue\" target=\"_blank\">result</a>.</li>     <li><a href='https://seekingalpha.com/symbol/NSPR' title='InspireMD, Inc.'>NSPR</a> <font color='green'>+9%</font>&nbsp;as CGuard EPS <a href=\"https://seekingalpha.com/news/3360238-inspiremds-cguard-eps-shows-sustained-benefit-extension-study-shares-ahead-8-percent\" target=\"_blank\">shows</a> sustained benefit in extension study.</li>     <li><a href='https://seekingalpha.com/symbol/TXMD' title='TherapeuticsMD'>TXMD</a> <font color='green'>+7%</font>&nbsp;on&nbsp;FDA <a href=\"https://seekingalpha.com/news/3360204-therapeuticsmd-announces-fda-approval-txminus-004hr-imvexxy-treatment-dyspareunia\" target=\"_blank\">approval</a> of TX-004HR.</li>     <li><a href='https://seekingalpha.com/symbol/KTOV' title='Kitov Pharma Ltd.'>KTOV</a> <font color='green'>+6%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/AXON' title='Axovant Sciences'>AXON</a> <font color='green'>+5%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/DCIX' title='Diana Containerships Inc.'>DCIX</a> <font color='green'>+5%</font>&nbsp;on time charter <a href=\"https://seekingalpha.com/pr/17177188-diana-containerships-inc-announces-time-charter-contract-m-v-rotterdam-wan-hai-lines\" target=\"_blank\">contract</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3360292\" data-linked=\"Premarket Gainers as of 9:05 am (05/30/2018)\" data-tweet=\"$OGEN $OGEN $CODX - Premarket Gainers as of 9:05 am (05/30/2018) https://seekingalpha.com/news/3360292-premarket-gainers-of-9-05-05-30-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3360292-premarket-gainers-of-9-05-05-30-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:21 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360291\" data-ts=\"1527686473\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HUM\" target=\"_blank\">HUM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360291-humana-down-10-premarket-on-light-volume\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Humana down 10% premarket on light volume</a></h4><ul><li>Humana (NYSE:<a href='https://seekingalpha.com/symbol/HUM' title='Humana Inc.'>HUM</a>) is down&nbsp;<font color='red'>10%</font>&nbsp;premarket, albeit on only 1,000 shares. The only relevant news appears to be a <a href=\"https://www.mmahotstuff.com/2018/05/30/regions-financial-has-decreased-its-altria-group-mo-position-bridger-management-trimmed-its-humana-hum-holding.html\" target=\"_blank\">modest sale</a> by institutional investor Bridger Management LLC, which sold 50,178 shares last quarter, trimming its stake by 16.5%.</li></ul><div class=\"tiny-share-widget\" data-id=\"3360291\" data-linked=\"Humana down 10% premarket on light volume\" data-tweet=\"$HUM - Humana down 10% premarket on light volume https://seekingalpha.com/news/3360291-humana-down-10-premarket-on-light-volume?source=tweet\" data-url=\"https://seekingalpha.com/news/3360291-humana-down-10-premarket-on-light-volume\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360284\" data-ts=\"1527685908\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AKS\" target=\"_blank\">AKS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360284-ak-steelminus-2-goldman-cuts-to-sell-4-price-target\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AK Steel -2% as Goldman cuts to Sell with $4 price target</a></h4><ul>     <li>AK&nbsp;Steel (NYSE:<a href='https://seekingalpha.com/symbol/AKS' title='AK Steel Holding Corp'>AKS</a>) <font color='red'>-1.8%</font> premarket after Goldman Sachs <a href=\"https://www.cnbc.com/2018/05/30/goldman-downgrades-ak-steel-to-sell.html\" target=\"_blank\">downgrades shares to Sell</a> from Neutral with a $4 price target, cut from $6, citing increased competition within its core automotive U.S. business.</li>     <li>Goldman says AKS <a href=\"https://thefly.com/thestreet/realmoney/index.php/AKSid2737721/AKS-AK-Steel-downgraded-to-Sell-at-Goldman-Sachs-on-disappointing-margins-pricing\" target=\"_blank\">continues to underperform</a> in terms of pricing and margins, and points to its limited visibility around downstream operations.</li>          <li>Goldman notes AKS now trades below its level from early November 2016, giving back all the gains made following Pres. Trump's election, and with weaker than expected quarterly guidance on pricing and profits, the firm thinks shares could fall further.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3360284\" data-linked=\"AK Steel -2% as Goldman cuts to Sell with $4 price target\" data-tweet=\"$AKS - AK Steel -2% as Goldman cuts to Sell with $4 price target https://seekingalpha.com/news/3360284-ak-steelminus-2-goldman-cuts-to-sell-4-price-target?source=tweet\" data-url=\"https://seekingalpha.com/news/3360284-ak-steelminus-2-goldman-cuts-to-sell-4-price-target\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:11 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360282\" data-ts=\"1527685837\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MTCH\" target=\"_blank\">MTCH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360282-deutsche-bank-resumes-match-group-15-upside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Deutsche Bank resumes Match Group at 15% upside</a></h4><ul><li>        Deutsche Bank resumes Match Group (NASDAQ:<a href='https://seekingalpha.com/symbol/MTCH' title='Match Group, Inc.'>MTCH</a>) at a Buy rating with a $47 price target.</li><li>               Target represents a 15% upside to yesterday&rsquo;s close.&nbsp;</li><li>               Source: Briefing.com.&nbsp;</li><li>               Match Group shares are&nbsp;<font color='green'>up 1.6%</font>&nbsp;premarket to $41.50.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3360282\" data-linked=\"Deutsche Bank resumes Match Group at 15% upside\" data-tweet=\"$MTCH - Deutsche Bank resumes Match Group at 15% upside https://seekingalpha.com/news/3360282-deutsche-bank-resumes-match-group-15-upside?source=tweet\" data-url=\"https://seekingalpha.com/news/3360282-deutsche-bank-resumes-match-group-15-upside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:10 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360281\" data-ts=\"1527685815\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MPW\" target=\"_blank\">MPW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360281-medical-properties-trust-to-divest-interest-in-ernest-health-for-175m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Medical Properties Trust to divest interest in Ernest Health for $175M</a></h4><ul><li>Medical Properties Trust (NYSE:<a href='https://seekingalpha.com/symbol/MPW' title='Medical Properties Trust, Inc.'>MPW</a>) has agreed to <a href=\"https://seekingalpha.com/pr/17177102-medical-properties-trust-inc-agrees-sell-equity-investment-ernest-health-inc-one-equity\" target=\"_blank\">sell its interest</a> in Ernest Health to affiliates of One Equity Partners for $175M, representing an unlevered 13% ROI. The transaction should close in H2. Proceeds will be used to pay down borrowings under its credit revolver.</li><li>MPT continues to own real estate interests of 25 post-acute hospitals operated by Ernest representing an aggregate investment of $500M.</li><li>Shares are down&nbsp;<font color='red'>1%</font>&nbsp;premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3360281\" data-linked=\"Medical Properties Trust to divest interest in Ernest Health for $175M\" data-tweet=\"$MPW - Medical Properties Trust to divest interest in Ernest Health for $175M https://seekingalpha.com/news/3360281-medical-properties-trust-to-divest-interest-in-ernest-health-for-175m?source=tweet\" data-url=\"https://seekingalpha.com/news/3360281-medical-properties-trust-to-divest-interest-in-ernest-health-for-175m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:10 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360280\" data-ts=\"1527685770\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHS\" target=\"_blank\">CHS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360280-premarket-losers-of-9-05-5-30-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am (5/30/2018)</a></h4><ul> <li><a href='https://seekingalpha.com/symbol/CHS' title='Chico&#39;s FAS, Inc.'>CHS</a>&nbsp;<font color='red'>-16%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3360221-chicos-fas-misses-0_03-beats-revenue\" target=\"_blank\">Q1 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/ADOM' title='ADOMANI, Inc.'>ADOM</a> <font color='red'>-5%</font>.</li><li><a href='https://seekingalpha.com/symbol/EKSO' title='Ekso Bionics Holdings, Inc.'>EKSO</a> <font color='red'>-7%</font>.</li><li><a href='https://seekingalpha.com/symbol/TTOO' title='T2 Biosystems'>TTOO</a>&nbsp;<font color='red'>-6%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3360112-t2-biosystems-readies-equity-offering-shares-9-percent-hours\" target=\"_blank\">announcing</a> common stock offering.</li><li>KORS&nbsp;<font color='red'>-6%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3360192-michael-kors-holdings-beats-0_03-beats-revenue\" target=\"_blank\">Q4 earnings</a>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3360280\" data-linked=\"Premarket Losers as of 9:05 am (5/30/2018)\" data-tweet=\"$CHS $CHS $ADOM - Premarket Losers as of 9:05 am (5/30/2018) https://seekingalpha.com/news/3360280-premarket-losers-of-9-05-5-30-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3360280-premarket-losers-of-9-05-5-30-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:09 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360277\" data-ts=\"1527685407\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360277-maxim-group-downgrades-apple-on-subscription-concerns\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Maxim Group downgrades Apple on subscription concerns</a></h4><ul><li>        Maxim Group <a href=\"https://www.cnbc.com/2018/05/30/apple-gets-downgraded-on-concern-services-focus-wont-deliver-big-profits.html\" target=\"_blank\">downgrades</a> Apple (NASDAQ:<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a>) from Buy to Hold and lowers the price target from $204 to $200, a 6% upside to yesterday&rsquo;s close.</li><li>               Analyst Nehal Chokshi cites concerns about the services business and subscriptions: &ldquo;We believe at best AAPL&rsquo;s subscription businesses at maturity will generate an operating margin in-line with the current corporate average of ~25% with some risk that actual long-term OM [operating margin] will be lower.&rdquo;&nbsp;</li><li>               Apple shares are&nbsp;<font color='red'>down 0.13%</font>&nbsp;premarket to $187.65.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3360277\" data-linked=\"Maxim Group downgrades Apple on subscription concerns\" data-tweet=\"$AAPL - Maxim Group downgrades Apple on subscription concerns https://seekingalpha.com/news/3360277-maxim-group-downgrades-apple-on-subscription-concerns?source=tweet\" data-url=\"https://seekingalpha.com/news/3360277-maxim-group-downgrades-apple-on-subscription-concerns\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>72&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360274\" data-ts=\"1527685252\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TXMD\" target=\"_blank\">TXMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360274-cowen-says-buy-therapeuticsmd-after-fda-nod-on-imvexxy-shares-up-5-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cowen says &quot;buy more&quot; TherapeuticsMD after FDA nod on Imvexxy; shares up 5% premarket</a></h4><ul><li>In a note, Cowen's Ken Cacciatore (Outperform/$16) says investors should \"add positions\" of TherapeuticsMD (NYSEMKT:<a href='https://seekingalpha.com/symbol/TXMD' title='TherapeuticsMD'>TXMD</a>) on the FDA approval of Imvexxy (estradiol vaginal insert) for the treatment of menopausal women experiencing vaginal pain during sexual activity.</li><li>Mr. Cacciatore cites the company's healthy cash balance ($107M as of March 31) to support market launch and survey results that showed clinicians are \"enthusiastic\" about the drug's profile.</li><li>Cantor's William Tanner adds that the company can access $75M via a recent loan agreement, if necessary.</li><li>Shares are up&nbsp;<font color='green'>5%</font>&nbsp;premarket on robust volume.</li><li>Source: Bloomberg</li><li>Previously: <a href=\"https://seekingalpha.com/news/3360204-therapeuticsmd-announces-fda-approval-txminus-004hr-imvexxy-treatment-dyspareunia\" target=\"_blank\">TherapeuticsMD announces FDA approval of TX-004HR: IMVEXXY for the treatment of dyspareunia</a> (May 30)</li><li><strong>Update</strong>: Investors appear to be ignoring Mr. Cacciatore. Shares are down&nbsp;<font color='red'>5%</font>&nbsp;in the last hour of the session.</li></ul><div class=\"tiny-share-widget\" data-id=\"3360274\" data-linked=\"Cowen says &quot;buy more&quot; TherapeuticsMD after FDA nod on Imvexxy; shares up 5% premarket\" data-tweet=\"$TXMD - Cowen says &quot;buy more&quot; TherapeuticsMD after FDA nod on Imvexxy; shares up 5% premarket https://seekingalpha.com/news/3360274-cowen-says-buy-therapeuticsmd-after-fda-nod-on-imvexxy-shares-up-5-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3360274-cowen-says-buy-therapeuticsmd-after-fda-nod-on-imvexxy-shares-up-5-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3360270\" data-ts=\"1527684974\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PANW\" target=\"_blank\">PANW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3360270-stifel-raises-palo-alto-target-to-15-upside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stifel raises its Palo Alto target to 15% upside</a></h4><ul><li>        Stifel raises its Palo Alto Networks (NYSE:<a href='https://seekingalpha.com/symbol/PANW' title='Palo Alto Networks'>PANW</a>) price target from $200 to $240, a 15% upside to yesterday&rsquo;s close.</li><li>               Firm cites optimism in Palo Alto&rsquo;s ability to sustain its improved execution.&nbsp;</li><li>               Stifel has conducted multiple checks on Palo Alto&rsquo;s Q3 (reports June 4) and expects results pointing to a sustained momentum following a string of strong prints for the past year.&nbsp;</li><li>               Source: Briefing.com.&nbsp;</li><li>               Palo Alto shares are&nbsp;<font color='green'>up 1.03%</font>&nbsp;premarket to $210.&nbsp; &nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3360270\" data-linked=\"Stifel raises its Palo Alto target to 15% upside\" data-tweet=\"$PANW - Stifel raises its Palo Alto target to 15% upside https://seekingalpha.com/news/3360270-stifel-raises-palo-alto-target-to-15-upside?source=tweet\" data-url=\"https://seekingalpha.com/news/3360270-stifel-raises-palo-alto-target-to-15-upside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:56 AM </div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}